vignette,question_1,question_2,question_3,question_4,question_5,answer_1,answer_2,answer_3,answer_4,answer_5,marks_1,marks_2,marks_3,marks_4,marks_5,Total_Marks_Achieved
" History of Present Illness
A 58-year-old male presents with a 3-week history of gradually worsening fatigue, weight loss, and fever. Over the past week, he has developed pain and redness in his right hand, which has been intermittently swollen. He denies trauma or any recent infections. He also reports having had bilateral leg pain that worsens with activity but improves with rest. The patient has no history of similar symptoms. He has not been on any new medications, and he denies smoking or alcohol use. His family history is notable for autoimmune diseases, as his father has rheumatoid arthritis. 

  Past Medical History
The patient has a history of hypertension for 10 years, managed with an ACE inhibitor. He has no known history of autoimmune diseases or vasculitis. He underwent a cholecystectomy 5 years ago . 

  Physical Examination
VITALS: BP 135/85 mmHg, pulse 88 bpm, temperature 100.4°F. 
GEN: Ill-appearing, mildly febrile, visibly fatigued. 
CARDIAC: Regular rhythm, no murmurs, Feeble peripheral pulses 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: Swelling and erythema of the right hand with tenderness to palpation at the metacarpophalangeal joint. Bilateral calf tenderness with no signs of deep venous thrombosis. 
EXT: No edema, but marked tenderness in the lower extremities. 
SKIN: Petechial rash over the anterior shin. 

  Laboratory Results
WBC: 12 x 103 cells/μL (elevated). Hemoglobin: 11.8 g/dL. ESR: 65 mm/h (elevated). Positive anti-ds DNA antibodies. CRP: 45 mg/L (elevated). Urinalysis: 2+ protein, no blood. Creatinine: 1.2 mg/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Systemic Lupus Erythematosus (SLE)**: The patient's symptoms of fatigue, weight loss, fever, joint pain, and swelling, along with laboratory results showing elevated ESR, CRP, and positive anti-ds DNA antibodies, are consistent with SLE. The presence of a petechial rash and proteinuria also support this diagnosis.
2. **Rheumatoid Arthritis (RA)**: The patient's symptoms of joint pain, swelling, and tenderness, particularly in the hands and feet, along with a family history of RA, suggest a possible diagnosis of RA. However, the presence of systemic symptoms such as fever and weight loss, as well as the laboratory results, may indicate a more systemic disease process.
3. **Vasculitis (e.g. Polyarteritis Nodosa or Giant Cell Arteritis)**: The patient's symptoms of fever, weight loss, and fatigue, along with laboratory results showing elevated inflammatory markers (ESR, CRP), and the presence of a petechial rash and tenderness in the lower extremities, may suggest a vasculitic process. The absence of a clear traumatic or infectious trigger, along with the patient's age and sex, may also support this diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Systemic Lupus Erythematosus (SLE)**

Supporting findings and risk factors:

* Positive anti-ds DNA antibodies: a specific and sensitive marker for SLE
* Elevated ESR (65 mm/h) and CRP (45 mg/L): indicate active inflammation, which is common in SLE
* Proteinuria (2+ protein on urinalysis): suggests renal involvement, which is a common feature of SLE
* Petechial rash: a common skin manifestation of SLE
* Fever, fatigue, and weight loss: nonspecific symptoms that are common in SLE
* Family history of autoimmune diseases (father with rheumatoid arthritis): suggests a possible genetic predisposition to autoimmune diseases, including SLE
* Absence of other clear explanations for the patient's symptoms: SLE is a diagnosis of exclusion, and the presence of multiple systemic symptoms and laboratory abnormalities without another clear explanation supports this diagnosis

**2. Rheumatoid Arthritis (RA)**

Supporting findings and risk factors:

* Family history of RA (father with rheumatoid arthritis): suggests a possible genetic predisposition to RA
* Joint pain and swelling, particularly in the hands (metacarpophalangeal joint) and feet: typical joint involvement in RA
* Morning stiffness and tenderness: common symptoms in RA
* Elevated ESR (65 mm/h) and CRP (45 mg/L): indicate active inflammation, which is common in RA
* Bilateral calf tenderness: may indicate enthesitis or tendonitis, which can occur in RA
* However, the presence of systemic symptoms such as fever, weight loss, and a petechial rash is less typical for RA and may suggest a more systemic disease process

**3. Vasculitis (e.g. Polyarteritis Nodosa or Giant Cell Arteritis)**

Supporting findings and risk factors:

* Fever, weight loss, and fatigue: nonspecific symptoms that can occur in vasculitis
* Petechial rash: a common skin manifestation of vasculitis
* Elevated ESR (65 mm/h) and CRP (45 mg/L): indicate active inflammation, which is common in vasculitis
* Tenderness in the lower extremities: may indicate vasculitic involvement of the peripheral nerves or blood vessels
* Absence of other clear explanations for the patient's symptoms: vasculitis is a diagnosis of exclusion, and the presence of multiple systemic symptoms and laboratory abnormalities without another clear explanation supports this diagnosis
* Age and sex: while vasculitis can occur at any age, some forms (e.g. giant cell arteritis) are more common in older adults, and the patient's age (58) and sex (male) may be consistent with certain types of vasculitis.","Here are the findings that oppose each of the possible diagnoses, or findings that were expected but not present:

**1. Systemic Lupus Erythematosus (SLE)**

Opposing findings:

* Absence of other specific autoantibodies (e.g. ANA, anti-Sm, anti-Ro, anti-La): while the patient has positive anti-ds DNA antibodies, the absence of other specific autoantibodies may suggest a different diagnosis
* No clear history of photosensitivity, oral ulcers, or alopecia: these are common symptoms in SLE, and their absence may suggest a different diagnosis
* No significant lymphadenopathy or hepatosplenomegaly: these are common findings in SLE, and their absence may suggest a different diagnosis
* Normal urinalysis (except for 2+ protein): while the patient has proteinuria, the absence of hematuria, casts, or other urinary abnormalities may suggest a different diagnosis
* The patient's symptoms and laboratory results are not as severe as typically seen in SLE: the patient's condition may be more mild or atypical than typical SLE

Expected findings that are not present:

* Mucosal ulcers: these are common in SLE, but not present in this patient
* Serositis (pleuritis or pericarditis): these are common in SLE, but not present in this patient
* Neurological symptoms (e.g. seizures, psychosis): these are common in SLE, but not present in this patient

**2. Rheumatoid Arthritis (RA)**

Opposing findings:

* Absence of morning stiffness: this is a common symptom in RA, and its absence may suggest a different diagnosis
* No clear evidence of symmetric joint involvement: RA typically involves symmetric joint involvement, but the patient's symptoms are more asymmetric
* No significant joint deformities or erosions: these are common findings in RA, and their absence may suggest a different diagnosis
* The patient's systemic symptoms (fever, weight loss) are not typical for RA: RA is typically a joint disease, and the presence of systemic symptoms may suggest a different diagnosis
* The patient's laboratory results (e.g. positive anti-ds DNA antibodies) are not typical for RA: RA is typically associated with rheumatoid factor and anti-CCP antibodies, not anti-ds DNA antibodies

Expected findings that are not present:

* Rheumatoid nodules: these are common in RA, but not present in this patient
* Significant joint swelling or effusions: these are common in RA, but not present in this patient
* Elevated rheumatoid factor or anti-CCP antibodies: these are common in RA, but not present in this patient

**3. Vasculitis (e.g. Polyarteritis Nodosa or Giant Cell Arteritis)**

Opposing findings:

* Absence of clear evidence of organ involvement (e.g. renal, gastrointestinal, or neurological symptoms): vasculitis typically involves multiple organ systems, and the absence of clear evidence of organ involvement may suggest a different diagnosis
* No significant hypertension or renal dysfunction: these are common findings in vasculitis, and their absence may suggest a different diagnosis
* The patient's symptoms and laboratory results are not as severe as typically seen in vasculitis: the patient's condition may be more mild or atypical than typical vasculitis
* No clear evidence of aneurysms or vascular stenosis: these are common findings in vasculitis, and their absence may suggest a different diagnosis

Expected findings that are not present:

* Significant eosinophilia: this is common in certain types of vasculitis (e.g. Churg-Strauss syndrome), but not present in this patient
* Clear evidence of granulomatous inflammation: this is common in certain types of vasculitis (e.g. giant cell arteritis), but not present in this patient
* Elevated levels of inflammatory markers (e.g. IL-6, TNF-alpha): these are common in vasculitis, but not significantly elevated in this patient","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Systemic Lupus Erythematosus (SLE)**

The patient's symptoms and laboratory results are consistent with SLE, including:

* Positive anti-ds DNA antibodies, which are a specific and sensitive marker for SLE
* Elevated ESR and CRP, which indicate active inflammation
* Proteinuria, which suggests renal involvement
* Petechial rash, which is a common skin manifestation of SLE
* Fever, fatigue, and weight loss, which are nonspecific symptoms that are common in SLE
* Family history of autoimmune diseases, which suggests a possible genetic predisposition to SLE

While the patient's symptoms and laboratory results could also be consistent with other diagnoses, such as rheumatoid arthritis or vasculitis, the presence of positive anti-ds DNA antibodies and the combination of systemic symptoms and laboratory results make SLE the most likely diagnosis.

The patient's symptoms and laboratory results do not meet the full criteria for a diagnosis of rheumatoid arthritis, and the absence of clear evidence of organ involvement and significant eosinophilia make vasculitis a less likely diagnosis.

**Classification criteria:**

The patient's symptoms and laboratory results meet the 1997 American College of Rheumatology (ACR) classification criteria for SLE, which include:

* Positive anti-ds DNA antibodies
* Proteinuria
* Petechial rash
* Fever
* Fatigue
* Weight loss

The patient's symptoms and laboratory results also meet the 2012 Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for SLE, which include:

* Positive anti-ds DNA antibodies
* Proteinuria
* Petechial rash
* Fever
* Fatigue
* Weight loss
* Elevated ESR and CRP

**Treatment:**

The patient will be started on a treatment regimen that includes:

* Corticosteroids (e.g. prednisone) to reduce inflammation and suppress the immune system
* Immunosuppressive medications (e.g. hydroxychloroquine, azathioprine) to reduce the risk of organ damage and prevent disease flares
* Anti-inflammatory medications (e.g. NSAIDs) to reduce pain and inflammation
* Close monitoring of the patient's symptoms, laboratory results, and organ function to adjust the treatment regimen as needed.

**Prognosis:**

The patient's prognosis is good, with a high likelihood of achieving remission with treatment. However, the patient will require close monitoring and regular follow-up appointments to adjust the treatment regimen as needed and prevent disease flares.","Based on the final diagnosis of Systemic Lupus Erythematosus (SLE), the following additional steps should be taken:

**Immediate steps:**

1. **Initiate corticosteroid therapy**: Start the patient on a moderate to high dose of corticosteroids (e.g. prednisone 20-40 mg/day) to reduce inflammation and suppress the immune system.
2. **Monitor vital signs and laboratory results**: Closely monitor the patient's vital signs, including blood pressure, temperature, and pulse, as well as laboratory results, including complete blood count (CBC), electrolyte panel, and liver function tests (LFTs).
3. **Assess for signs of organ involvement**: Evaluate the patient for signs of organ involvement, such as renal dysfunction, cardiovascular disease, or neurological symptoms.

**Short-term steps:**

1. **Immunosuppressive therapy**: Consider adding immunosuppressive medications (e.g. hydroxychloroquine, azathioprine) to the patient's treatment regimen to reduce the risk of organ damage and prevent disease flares.
2. **Anti-inflammatory therapy**: Continue anti-inflammatory medications (e.g. NSAIDs) to reduce pain and inflammation.
3. **Monitor for disease flares**: Regularly assess the patient for signs of disease flares, such as increased fatigue, joint pain, or rash.

**Long-term steps:**

1. **Regular follow-up appointments**: Schedule regular follow-up appointments with the patient to monitor disease activity, adjust the treatment regimen as needed, and prevent disease flares.
2. **Lifestyle modifications**: Encourage the patient to make lifestyle modifications, such as maintaining a healthy diet, exercising regularly, and managing stress, to reduce the risk of disease flares.
3. **Screening for comorbidities**: Regularly screen the patient for comorbidities, such as osteoporosis, cardiovascular disease, and depression, which are common in patients with SLE.

**Specialized care:**

1. **Rheumatology consultation**: Consider consulting a rheumatologist to confirm the diagnosis and develop a treatment plan.
2. **Nephrology consultation**: If the patient has significant renal involvement, consider consulting a nephrologist to manage renal disease.
3. **Cardiology consultation**: If the patient has significant cardiovascular disease, consider consulting a cardiologist to manage cardiovascular risk factors.

**Patient education:**

1. **Disease education**: Educate the patient about SLE, its symptoms, and its treatment options.
2. **Medication management**: Educate the patient about their medication regimen, including dosing, side effects, and potential interactions.
3. **Self-management techniques**: Teach the patient self-management techniques, such as stress management, exercise, and healthy eating, to reduce the risk of disease flares.","{""Score"":3,""Rationale"":""All three diagnoses (Systemic Lupus Erythematosus, Rheumatoid Arthritis, Vasculitis) match items listed in the high‑scoring example, earning the full 3 points.""}","{""Score"":6,""Rationale"":""Student correctly identified and provided supporting findings for Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Vasculitis that match the concepts in the high‑scoring example. These three diagnoses account for the full 6‑point total as defined in the rubric.""}","{""Score"":5,""Rationale"":""The answer matches the rubric concepts for Rheumatoid Arthritis (absence of morning stiffness and joint deformities) and Vasculitis (no organ/vessel involvement and no characteristic imaging findings), earning full points for those sections. For Systemic Lupus Erythematosus, only the lack of renal involvement is mentioned, which matches one rubric concept, but the absence of butterfly rash is not addressed, resulting in partial credit. Hence, 1 point for SLE + 2 points for RA + 2 points for Vasculitis = 5 points out of 6.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Systemic Lupus Erythematosus (SLE) and lists the key clinical findings (fever, weight loss, elevated ESR/CRP, rash, proteinuria) that match the high‑scoring example, thus earning full credit.""}","{""Score"":4,""Rationale"":""The answer includes a rheumatology consultation (referral) and mentions hydroxychloroquine as part of immunosuppressive therapy, matching two rubric items (2 points each). It does not mention performing a kidney biopsy for proteinuria, so no points for that item.""}",20.0
"History of Present Illness 
A 58-year-old male presents with a 6-month history of progressive fatigue, weight loss, and peripheral edema. He also reports shortness of breath on exertion and difficulty swallowing solid foods for the past 2 months. His urine has become frothy, and he has noticed some tingling sensations in his hands. He denies chest pain, fever, or night sweats. There is no history of hypertension, diabetes, or known heart disease. 
Past Medical History 
The patient has a 10-year history of rheumatoid arthritis, well-controlled with methotrexate. He denies smoking or alcohol use. Family history is negative for any genetic disorders. 
Physical Examination 
VITALS: BP 110/70 mmHg, pulse 90/min, temperature 98.4°F. 
GEN: Thin, pale, fatigued. 
CARDIAC: No murmurs, but there is a slight periorbital edema. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild hepatomegaly (2 cm below the costal margin), no tenderness. 
EXT: Bilateral pedal edema, no erythema or ulcers. 
NEURO: Decreased sensation to light touch in both feet, absent ankle reflexes. 

Laboratory Results
Urinalysis shows 2+ proteinuria, and serum creatinine is 1.5 mg/dL. The BNP is elevated at 550 pg/mL. Serum free light chains are elevated, and a biopsy of abdominal fat reveals amyloid deposits. Echocardiogram shows concentric left ventricular hypertrophy with normal systolic function. Hemoglobin levels within normal range.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Amyloid Light-Chain (AL) Amyloidosis**: The presence of elevated serum free light chains, proteinuria, and amyloid deposits in the abdominal fat biopsy are consistent with AL amyloidosis, a condition where abnormal proteins (light chains) produced by plasma cells accumulate in tissues and organs, leading to organ dysfunction.
2. **Cardiac Amyloidosis**: The patient's symptoms of shortness of breath, peripheral edema, and elevated BNP, along with the echocardiogram showing concentric left ventricular hypertrophy, suggest cardiac involvement. Cardiac amyloidosis can lead to restrictive cardiomyopathy, which can cause heart failure symptoms.
3. **Systemic Amyloidosis with Rheumatoid Arthritis**: The patient's 10-year history of rheumatoid arthritis, a chronic inflammatory condition, may be related to the development of amyloidosis. Some patients with long-standing rheumatoid arthritis can develop secondary amyloidosis (AA amyloidosis), although the presence of elevated serum free light chains suggests AL amyloidosis is more likely in this case.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Amyloid Light-Chain (AL) Amyloidosis**

* **Elevated serum free light chains**: This is a key diagnostic criterion for AL amyloidosis, as it indicates the presence of abnormal light chain proteins in the blood.
* **Amyloid deposits in abdominal fat biopsy**: The presence of amyloid deposits in the biopsy is a definitive diagnostic finding for amyloidosis.
* **Proteinuria (2+)**: Kidney involvement is common in AL amyloidosis, and proteinuria is a frequent finding.
* **Weight loss and fatigue**: These are non-specific symptoms that can occur in AL amyloidosis due to the systemic nature of the disease.
* **History of rheumatoid arthritis**: While not a direct risk factor, chronic inflammatory conditions like rheumatoid arthritis can increase the risk of developing plasma cell dyscrasias, which can lead to AL amyloidosis.

**2. Cardiac Amyloidosis**

* **Elevated BNP (550 pg/mL)**: This is a marker of heart failure, and elevated BNP levels are common in cardiac amyloidosis.
* **Concentric left ventricular hypertrophy on echocardiogram**: This is a characteristic finding in cardiac amyloidosis, as the amyloid deposits can cause thickening of the heart muscle.
* **Shortness of breath on exertion**: This symptom is consistent with heart failure, which can occur in cardiac amyloidosis.
* **Peripheral edema**: This is another symptom of heart failure, which can be caused by cardiac amyloidosis.
* **Periorbital edema**: This finding is also consistent with cardiac amyloidosis, as the amyloid deposits can cause fluid accumulation in the body.

**3. Systemic Amyloidosis with Rheumatoid Arthritis**

* **10-year history of rheumatoid arthritis**: Chronic inflammatory conditions like rheumatoid arthritis can increase the risk of developing secondary amyloidosis (AA amyloidosis).
* **Systemic symptoms (weight loss, fatigue)**: These symptoms can occur in both rheumatoid arthritis and systemic amyloidosis.
* **Proteinuria (2+)**: Kidney involvement is common in both rheumatoid arthritis and systemic amyloidosis.
* **Neurological symptoms (tingling sensations, decreased sensation to light touch)**: These symptoms can occur in both rheumatoid arthritis and systemic amyloidosis, although they are more common in AL amyloidosis.
* **Mild hepatomegaly**: This finding can occur in both rheumatoid arthritis and systemic amyloidosis, as the liver can be involved in both conditions.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Amyloid Light-Chain (AL) Amyloidosis**

* **Normal hemoglobin levels**: AL amyloidosis is often associated with anemia, which is not present in this patient.
* **No lymphadenopathy or splenomegaly**: AL amyloidosis is often associated with plasma cell dyscrasias, which can cause lymphadenopathy or splenomegaly, but these findings are not present in this patient.
* **No monoclonal protein spike on serum protein electrophoresis (not reported)**: While elevated serum free light chains are present, a monoclonal protein spike on serum protein electrophoresis is often seen in AL amyloidosis, but this test result is not reported.
* **Normal blood pressure**: AL amyloidosis can cause autonomic dysfunction, leading to orthostatic hypotension, but this patient's blood pressure is normal.
* **No macroglossia**: AL amyloidosis can cause macroglossia (enlarged tongue), but this finding is not present in this patient.

**2. Cardiac Amyloidosis**

* **Normal systolic function on echocardiogram**: Cardiac amyloidosis often causes restrictive cardiomyopathy, which can lead to systolic dysfunction, but this patient's systolic function is normal.
* **No murmurs on cardiac examination**: Cardiac amyloidosis can cause murmurs due to valvular involvement, but no murmurs are present in this patient.
* **No signs of congestive heart failure (e.g., pulmonary edema)**: While the patient has shortness of breath and peripheral edema, there are no signs of congestive heart failure, which is often seen in cardiac amyloidosis.
* **Normal pulse pressure**: Cardiac amyloidosis can cause a low pulse pressure due to restrictive cardiomyopathy, but this patient's pulse pressure is normal.
* **No history of arrhythmias**: Cardiac amyloidosis can cause arrhythmias, but this patient has no history of arrhythmias.

**3. Systemic Amyloidosis with Rheumatoid Arthritis**

* **Elevated serum free light chains**: This finding is more consistent with AL amyloidosis than secondary amyloidosis (AA amyloidosis) associated with rheumatoid arthritis.
* **No history of chronic infections or chronic inflammatory conditions other than rheumatoid arthritis**: Secondary amyloidosis (AA amyloidosis) is often associated with chronic infections or inflammatory conditions, but this patient has no such history.
* **No signs of active rheumatoid arthritis (e.g., joint swelling, morning stiffness)**: While the patient has a history of rheumatoid arthritis, there are no signs of active disease, which is often seen in patients with secondary amyloidosis.
* **Normal liver function tests (not reported)**: Secondary amyloidosis can cause liver involvement, but liver function tests are not reported, and the patient has only mild hepatomegaly.
* **No history of kidney disease**: Secondary amyloidosis can cause kidney disease, but this patient has no history of kidney disease, and the proteinuria is a relatively recent finding.","Based on the patient's symptoms, physical examination, laboratory results, and biopsy findings, the final diagnosis is:

**Primary Systemic Amyloid Light-Chain (AL) Amyloidosis**

The key findings that support this diagnosis include:

1. **Elevated serum free light chains**: This is a hallmark of AL amyloidosis and indicates the presence of abnormal light chain proteins in the blood.
2. **Amyloid deposits in abdominal fat biopsy**: The presence of amyloid deposits in the biopsy is a definitive diagnostic finding for amyloidosis.
3. **Proteinuria (2+)**: Kidney involvement is common in AL amyloidosis, and proteinuria is a frequent finding.
4. **Cardiac involvement (elevated BNP, concentric left ventricular hypertrophy on echocardiogram)**: AL amyloidosis can cause cardiac involvement, leading to heart failure symptoms and abnormal echocardiogram findings.
5. **Neurological symptoms (tingling sensations, decreased sensation to light touch)**: AL amyloidosis can cause peripheral neuropathy, which is consistent with the patient's symptoms.

The patient's history of rheumatoid arthritis is likely coincidental, and the absence of other findings suggestive of secondary amyloidosis (AA amyloidosis) makes AL amyloidosis the most likely diagnosis.

**Treatment and Management:**

The treatment of AL amyloidosis typically involves a combination of chemotherapy, stem cell transplantation, and supportive care. The goal of treatment is to reduce the production of abnormal light chain proteins, alleviate symptoms, and improve quality of life.

In this patient's case, further evaluation and management by a hematologist and cardiologist would be necessary to determine the best course of treatment. This may include:

1. **Chemotherapy**: To reduce the production of abnormal light chain proteins.
2. **Stem cell transplantation**: To replace the patient's bone marrow with healthy stem cells.
3. **Supportive care**: To manage symptoms such as heart failure, proteinuria, and peripheral neuropathy.
4. **Dialysis**: If the patient's kidney function deteriorates, dialysis may be necessary.

Regular follow-up appointments with a hematologist, cardiologist, and nephrologist would be necessary to monitor the patient's condition and adjust treatment as needed.","Based on the final diagnosis of Primary Systemic Amyloid Light-Chain (AL) Amyloidosis, the following additional steps should be taken:

**Immediate Steps:**

1. **Referral to a Hematologist**: The patient should be referred to a hematologist for further evaluation and management of the AL amyloidosis.
2. **Cardiology Consultation**: A cardiology consultation should be arranged to further evaluate the patient's cardiac involvement and to determine the best course of treatment for the cardiac amyloidosis.
3. **Nephrology Consultation**: A nephrology consultation should be arranged to evaluate the patient's kidney function and to determine the best course of treatment for the renal involvement.

**Diagnostic Tests:**

1. **Bone Marrow Biopsy**: A bone marrow biopsy should be performed to assess the extent of plasma cell infiltration and to determine the presence of any other hematological abnormalities.
2. **Serum Protein Electrophoresis (SPEP)**: SPEP should be performed to identify and quantify the abnormal light chain proteins in the blood.
3. **Urinary Protein Electrophoresis (UPEP)**: UPEP should be performed to identify and quantify the abnormal light chain proteins in the urine.
4. **Echocardiogram with Strain Imaging**: An echocardiogram with strain imaging should be performed to further evaluate the patient's cardiac function and to assess the extent of cardiac involvement.
5. **Renal Ultrasound**: A renal ultrasound should be performed to evaluate the patient's kidney size and to assess for any signs of kidney damage.

**Treatment:**

1. **Chemotherapy**: The patient should be started on chemotherapy to reduce the production of abnormal light chain proteins.
2. **Stem Cell Transplantation**: The patient should be evaluated for stem cell transplantation to replace the bone marrow with healthy stem cells.
3. **Supportive Care**: The patient should receive supportive care to manage symptoms such as heart failure, proteinuria, and peripheral neuropathy.
4. **Dialysis**: If the patient's kidney function deteriorates, dialysis may be necessary.

**Follow-up:**

1. **Regular Hematology Follow-up**: The patient should have regular follow-up appointments with a hematologist to monitor the response to treatment and to adjust the treatment plan as needed.
2. **Regular Cardiology Follow-up**: The patient should have regular follow-up appointments with a cardiologist to monitor the cardiac involvement and to adjust the treatment plan as needed.
3. **Regular Nephrology Follow-up**: The patient should have regular follow-up appointments with a nephrologist to monitor the kidney function and to adjust the treatment plan as needed.

**Prognosis:**

The prognosis for AL amyloidosis is variable and depends on the extent of organ involvement and the response to treatment. With prompt and effective treatment, some patients can experience significant improvement in symptoms and quality of life. However, the disease can be fatal if left untreated or if treatment is delayed.","{""Score"":1,""Rationale"":""The answer includes Amyloidosis, which matches a rubric item. It does not include Congestive Cardiac Failure, Chronic Kidney Disease, or Multiple Myeloma, so only one point is awarded.""}","{""Score"":2,""Rationale"":""Student correctly identifies AL amyloidosis, matching the Amyloidosis concept in the rubric (2 points). They do not mention Congestive Cardiac Failure, Chronic Kidney Disease, or Multiple Myeloma, so no points for those items.""}","{
  ""Score"": 0,
  ""Rationale"": ""The answer does not provide the specific opposing findings for Amyloidosis, Congestive Cardiac Failure, Chronic Kidney Disease, or mention amyloid deposition on biopsy and absence of Bence Jones proteins as required by the rubric. None of the rubric's listed concepts are matched.""
}","{""Score"":2,""Rationale"":""Student correctly identified amyloidosis and provided supporting findings (biopsy confirming amyloid deposits, proteinuria, neuropathy) that match the high-scoring example.""}","{""Score"":2,""Rationale"":""The answer includes Bone Marrow Biopsy, which matches one of the three required items. It does not mention Cardiac MRI or Renal Biopsy, so only 2 of the 6 possible points are earned.""}",7.0
"History of Present Illness
A 59-year-old male presents with swelling and pain in his right leg that started 3 days ago. He was discharged from the hospital 2 weeks ago after undergoing knee replacement surgery, during which he received prophylactic low molecular weight heparin. He reports intermittent fever and recent episodes of palpitations. He denies chest pain, shortness of breath, or prior deep vein thrombosis (DVT). 

  Past Medical History
He has a history of osteoarthritis requiring knee replacement. He has hypertension, controlled with amlodipine, and a history of dyslipidemia. He has no history of malignancy or clotting disorders. 

  Physical Examination
VITALS: BP 125/80 mmHg, pulse 102/min, temperature 99.6°F. 
GEN: Appears mildly uncomfortable. 
CARDIAC: Regular rhythm, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender. 
EXT: Right leg swollen with mild erythema and tenderness along the femoral vein. Homans' sign is positive. No ulcers or skin changes. 
SKIN: Petechiae on both forearms. 

  Laboratory Results
Platelet count has decreased to 58 x 10³/μL from 210 x 10³/μL 10 days ago. D-dimer is elevated at 5.2 μg/mL. The Heparin-PF4 antibody test is positive. Ultrasound reveals a thrombus in the right femoral vein.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Heparin-Induced Thrombocytopenia (HIT)**: The patient has a history of recent heparin use, a significant decrease in platelet count, and a positive Heparin-PF4 antibody test, which are all consistent with HIT.
2. **Deep Vein Thrombosis (DVT)**: The patient presents with swelling, pain, and tenderness in the right leg, and ultrasound reveals a thrombus in the right femoral vein, which is consistent with DVT.
3. **Thromboembolic Disease**: The patient's symptoms, including intermittent fever, palpitations, and petechiae, along with the elevated D-dimer and thrombus in the femoral vein, suggest a possible thromboembolic disease, which could be related to the DVT or HIT.","Here are the findings and risk factors supporting each possible diagnosis:

**1. Heparin-Induced Thrombocytopenia (HIT)**

* Recent use of prophylactic low molecular weight heparin after knee replacement surgery
* Significant decrease in platelet count (from 210 x 10³/μL to 58 x 10³/μL) within 10 days of heparin use
* Positive Heparin-PF4 antibody test
* Presence of thrombosis (thrombus in the right femoral vein) despite heparin use
* Petechiae on both forearms, which could be a sign of thrombocytopenia

**2. Deep Vein Thrombosis (DVT)**

* Recent knee replacement surgery, which is a major orthopedic surgery and a known risk factor for DVT
* Swelling, pain, and tenderness in the right leg, which are classic symptoms of DVT
* Positive Homans' sign, which is a physical examination finding suggestive of DVT
* Ultrasound confirmation of a thrombus in the right femoral vein
* Elevated D-dimer level (5.2 μg/mL), which is a marker of thrombosis

**3. Thromboembolic Disease**

* Recent knee replacement surgery, which is a risk factor for thromboembolic disease
* Presence of DVT (thrombus in the right femoral vein), which increases the risk of thromboembolism
* Intermittent fever, which could be a sign of thromboembolic disease
* Palpitations, which could be a sign of pulmonary embolism or other thromboembolic events
* Elevated D-dimer level (5.2 μg/mL), which is a marker of thrombosis and thromboembolism
* Presence of petechiae, which could be a sign of thrombocytopenia or thromboembolic disease","Here are the findings opposing each possible diagnosis, or findings that were expected but not present:

**1. Heparin-Induced Thrombocytopenia (HIT)**

* The patient's platelet count decrease is significant, but it is not clear if it occurred within the typical 5-10 day timeframe after heparin initiation.
* The patient does not have any other typical symptoms of HIT, such as skin necrosis or acute systemic reactions.
* The presence of a thrombus in the femoral vein could be due to other causes, such as DVT, rather than HIT.
* Expected findings that are not present include:
	+ More severe thrombocytopenia (platelet count < 20 x 10³/μL)
	+ More pronounced elevation of D-dimer levels
	+ Presence of other thrombotic events, such as arterial thrombosis

**2. Deep Vein Thrombosis (DVT)**

* The patient does not have any symptoms of pulmonary embolism, such as shortness of breath or chest pain, which can be a complication of DVT.
* The patient's vital signs are relatively stable, with no significant tachycardia or hypotension, which can be seen in more severe cases of DVT.
* The patient's D-dimer level is elevated, but not extremely high, which could suggest a smaller or less severe DVT.
* Expected findings that are not present include:
	+ More severe swelling or edema in the affected leg
	+ Increased warmth or tenderness in the affected leg
	+ Presence of other signs of DVT, such as calf tenderness or swelling

**3. Thromboembolic Disease**

* The patient does not have any symptoms of pulmonary embolism, such as shortness of breath or chest pain, which can be a complication of thromboembolic disease.
* The patient's cardiac examination is normal, with no signs of right heart strain or other cardiac complications.
* The patient's oxygen saturation is not mentioned, but it is expected to be normal if there is no significant pulmonary embolism.
* Expected findings that are not present include:
	+ More severe or persistent symptoms, such as chest pain or shortness of breath
	+ Presence of other signs of thromboembolism, such as cardiac arrhythmias or hypotension
	+ Elevated troponin or other cardiac biomarkers, which can be seen in cases of thromboembolic disease with cardiac involvement.","Based on the patient's symptoms, laboratory results, and physical examination findings, the final diagnosis is:

**Heparin-Induced Thrombocytopenia (HIT) with Deep Vein Thrombosis (DVT)**

The patient's recent use of prophylactic low molecular weight heparin, significant decrease in platelet count, and positive Heparin-PF4 antibody test are all consistent with HIT. The presence of a thrombus in the right femoral vein, as confirmed by ultrasound, supports the diagnosis of DVT.

The patient's symptoms, including swelling, pain, and tenderness in the right leg, are consistent with DVT. The presence of petechiae on both forearms may be related to the thrombocytopenia associated with HIT.

The diagnosis of HIT with DVT is further supported by the patient's recent knee replacement surgery, which is a known risk factor for both HIT and DVT.

The patient's intermittent fever and palpitations may be related to the thromboembolic disease, but the absence of other symptoms such as shortness of breath or chest pain suggests that pulmonary embolism is less likely.

Overall, the patient's clinical presentation and laboratory results are most consistent with HIT with DVT, and treatment should be directed towards managing these conditions.","Based on the final diagnosis of Heparin-Induced Thrombocytopenia (HIT) with Deep Vein Thrombosis (DVT), the following additional steps should be taken:

1. **Discontinue all forms of heparin**: Immediately stop all heparin products, including low molecular weight heparin, to prevent further platelet activation and thrombosis.
2. **Initiate alternative anticoagulation**: Start an alternative anticoagulant, such as argatroban or fondaparinux, to prevent further thrombosis and manage the DVT.
3. **Monitor platelet count**: Closely monitor the patient's platelet count to assess the response to treatment and adjust the anticoagulation regimen as needed.
4. **Imaging studies**: Perform additional imaging studies, such as a CT scan or MRI, to rule out pulmonary embolism and assess the extent of the DVT.
5. **Thrombophilia workup**: Consider a thrombophilia workup to evaluate for underlying coagulation disorders that may have contributed to the development of HIT and DVT.
6. **Consultation with a hematologist**: Consult with a hematologist to discuss the management of HIT and DVT, and to determine the best course of treatment.
7. **Patient education**: Educate the patient on the risks and benefits of anticoagulation therapy, and provide instructions on how to manage the condition and prevent further complications.
8. **Follow-up care**: Schedule follow-up appointments to monitor the patient's condition, adjust the treatment plan as needed, and prevent long-term complications such as post-thrombotic syndrome.

In terms of specific treatment, the following options may be considered:

* **Argatroban**: 2-4 mcg/kg/min IV, adjusted to achieve an aPTT of 1.5-3 times the baseline value
* **Fondaparinux**: 7.5-10 mg SC once daily, adjusted based on renal function and body weight
* **Warfarin**: may be considered for long-term anticoagulation, but should be started only after the platelet count has recovered and the patient is no longer at risk for thrombosis.

It is essential to note that the management of HIT and DVT requires a multidisciplinary approach, and close collaboration with a hematologist, cardiologist, and other specialists may be necessary to ensure optimal care.","{""Score"":2,""Rationale"":""Heparin-Induced Thrombocytopenia (HIT) and Deep Vein Thrombosis (DVT) match the rubric; the third diagnosis (Thromboembolic Disease) is not listed (rubric expects Fat embolism), so only two points are awarded.""}","{""Score"":4,""Rationale"":""Student correctly identified Heparin-Induced Thrombocytopenia and Deep Vein Thrombosis with matching criteria, earning 2 points each. The third diagnosis is Thromboembolic Disease, which does not match the required Fat Embolism concept, so no points awarded for that item.""}","{""Score"":4,""Rationale"":""Student correctly identified HIT and DVT, matching two concepts from the rubric (2 points each). Did not include Fat Embolism and added Thromboembolic Disease, which is not in the rubric, so no points for the third item.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Heparin-Induced Thrombocytopenia (HIT) and includes all rubric‑listed features (recent heparin use, thrombocytopenia, positive Heparin‑PF4 antibody test, new thrombosis/petechiae). The additional mention of DVT does not negate the correct HIT diagnosis, so full credit is awarded.""}","{""Score"":6,""Rationale"":""The answer includes all three required actions: discontinuing all heparin products, initiating alternative anticoagulation (argatroban or fondaparinux), and closely monitoring platelet count, matching the high‑scoring example.""}",18.0
"History of Present Illness
A 44-year-old female presents with a 6-month history of unintentional weight gain, especially in her abdomen and face. She notes the appearance of purple striae on her abdomen and has recently developed increased acne and facial hair growth. She reports fatigue, insomnia, and mood swings. Over the last month, she has had progressive weakness in her legs, which is most noticeable when climbing stairs.

Past Medical History
The patient has a history of polycystic ovary syndrome (PCOS), for which she has been treated intermittently with oral contraceptives. She denies any history of diabetes or previous steroid use.

Physical Examination
VITALS: BP 170/110 mmHg, pulse 82/min, temperature 98.5°F.
GEN: Overweight, with moon facies and a central distribution of fat.
CARDIAC: Regular rhythm, no murmurs.
PULM: Clear to auscultation bilaterally.
ABD: Obese with prominent abdominal striae and a rounded abdomen.
EXT: Bilateral proximal muscle weakness, especially in the thighs.
SKIN: Purple striae on the abdomen, mild acne on the back and face.

Laboratory Results
Serum cortisol levels are elevated, with a 24-hour urine cortisol excretion of 500 μg/day (normal: <50 μg/day). ACTH is raised, and MRI of the pituitary gland shows a small adenoma.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Cushing's Syndrome**: The patient's symptoms such as weight gain, particularly in the abdominal and facial areas, purple striae, acne, facial hair growth, and muscle weakness are consistent with Cushing's syndrome. The elevated serum cortisol levels and 24-hour urine cortisol excretion also support this diagnosis.
2. **Cushing's Disease**: The presence of a pituitary adenoma on MRI, elevated ACTH, and elevated cortisol levels suggest that the patient may have Cushing's disease, which is a specific type of Cushing's syndrome caused by an ACTH-secreting pituitary tumor.
3. **Adrenal Cushing's Syndrome (less likely)**: Although less likely given the elevated ACTH levels, adrenal Cushing's syndrome is still a possible diagnosis. This condition is caused by excess cortisol production by the adrenal glands, which could be due to an adrenal tumor or hyperplasia. However, the presence of a pituitary adenoma and elevated ACTH levels make this diagnosis less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Cushing's Syndrome**

Supporting findings:

* **Clinical presentation**: The patient's symptoms such as weight gain (particularly in the abdominal and facial areas), purple striae, acne, facial hair growth, and muscle weakness are classic signs of Cushing's syndrome.
* **Elevated cortisol levels**: The patient's serum cortisol levels are elevated, and the 24-hour urine cortisol excretion is significantly higher than normal, which is a key diagnostic criterion for Cushing's syndrome.
* **Hypertension**: The patient's blood pressure is elevated (170/110 mmHg), which is a common finding in Cushing's syndrome due to the effects of excess cortisol on the cardiovascular system.
* **Moon facies and central obesity**: The patient's physical examination reveals a characteristic ""moon face"" and central distribution of fat, which are common features of Cushing's syndrome.

**2. Cushing's Disease**

Supporting findings:

* **Elevated ACTH levels**: The patient's ACTH levels are elevated, which suggests that the excess cortisol production is driven by an ACTH-secreting tumor, such as a pituitary adenoma.
* **Pituitary adenoma on MRI**: The presence of a small adenoma on the MRI of the pituitary gland is a strong supporting finding for Cushing's disease, as it suggests that the patient has a tumor that is secreting ACTH and causing the excess cortisol production.
* **Clinical presentation**: The patient's symptoms, such as weight gain, purple striae, acne, and muscle weakness, are consistent with Cushing's disease.
* **Response to dexamethasone suppression test (not performed)**: Although not performed in this case, a high-dose dexamethasone suppression test can help confirm the diagnosis of Cushing's disease by demonstrating that the ACTH-secreting tumor is responsive to glucocorticoid feedback.

**3. Adrenal Cushing's Syndrome (less likely)**

Supporting findings:

* **Elevated cortisol levels**: The patient's serum cortisol levels are elevated, which could be consistent with adrenal Cushing's syndrome.
* **Hypertension**: The patient's blood pressure is elevated, which could be related to the effects of excess cortisol on the cardiovascular system.
* **Clinical presentation**: The patient's symptoms, such as weight gain and purple striae, could be consistent with adrenal Cushing's syndrome.

However, the following findings make adrenal Cushing's syndrome less likely:

* **Elevated ACTH levels**: The patient's ACTH levels are elevated, which suggests that the excess cortisol production is driven by an ACTH-secreting tumor, rather than a primary adrenal disorder.
* **Pituitary adenoma on MRI**: The presence of a pituitary adenoma on MRI suggests that the patient has Cushing's disease, rather than adrenal Cushing's syndrome.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Cushing's Syndrome**

Opposing findings:

* **Absence of other classic signs**: Although the patient has some classic signs of Cushing's syndrome, such as weight gain and purple striae, other signs like buffalo hump, supraclavicular fat pads, and poor wound healing are not mentioned.
* **Normal temperature**: The patient's temperature is normal (98.5°F), whereas patients with Cushing's syndrome often have an increased risk of infections and may present with fever.
* **Lack of mention of other systemic symptoms**: The patient does not report other systemic symptoms like osteoporosis, kidney stones, or glaucoma, which can be associated with Cushing's syndrome.

Expected but not present findings:

* **Hyperglycemia**: Cushing's syndrome is often associated with glucose intolerance or diabetes, but the patient's past medical history does not mention diabetes, and no information is provided about her glucose levels.
* **Hypokalemia**: Cushing's syndrome can cause hypokalemia due to the effects of excess cortisol on potassium levels, but the patient's electrolyte levels are not provided.

**2. Cushing's Disease**

Opposing findings:

* **Absence of other pituitary hormone abnormalities**: The patient's presentation does not suggest other pituitary hormone abnormalities, such as hypogonadism, hypothyroidism, or growth hormone deficiency, which can be associated with pituitary adenomas.
* **Normal pulse**: The patient's pulse is normal (82/min), whereas patients with Cushing's disease may have an increased heart rate due to the effects of excess cortisol on the cardiovascular system.
* **Lack of mention of visual field defects**: The patient does not report any visual field defects, which can be associated with pituitary adenomas that compress the optic chiasm.

Expected but not present findings:

* **Galactorrhea or amenorrhea**: Cushing's disease can cause galactorrhea or amenorrhea in women due to the effects of excess cortisol on the hypothalamic-pituitary-gonadal axis, but the patient's past medical history mentions polycystic ovary syndrome (PCOS), which may have already caused menstrual irregularities.
* **Headaches or visual disturbances**: The patient does not report any headaches or visual disturbances, which can be associated with pituitary adenomas.

**3. Adrenal Cushing's Syndrome (less likely)**

Opposing findings:

* **Elevated ACTH levels**: The patient's ACTH levels are elevated, which suggests that the excess cortisol production is driven by an ACTH-secreting tumor, rather than a primary adrenal disorder.
* **Pituitary adenoma on MRI**: The presence of a pituitary adenoma on MRI suggests that the patient has Cushing's disease, rather than adrenal Cushing's syndrome.
* **Normal electrolyte levels (not provided)**: Adrenal Cushing's syndrome can cause hypokalemia due to the effects of excess cortisol on potassium levels, but the patient's electrolyte levels are not provided.

Expected but not present findings:

* **Adrenal mass on imaging**: Adrenal Cushing's syndrome is often associated with an adrenal mass or hyperplasia, but no information is provided about the patient's adrenal glands.
* **Low ACTH levels**: Adrenal Cushing's syndrome is typically associated with low ACTH levels due to negative feedback from the high cortisol levels, but the patient's ACTH levels are elevated.","Based on the patient's symptoms, physical examination, laboratory results, and imaging studies, the final diagnosis is:

**Cushing's Disease**

The diagnosis of Cushing's disease is supported by the following findings:

* **Elevated cortisol levels**: The patient's serum cortisol levels are elevated, and the 24-hour urine cortisol excretion is significantly higher than normal.
* **Elevated ACTH levels**: The patient's ACTH levels are elevated, which suggests that the excess cortisol production is driven by an ACTH-secreting tumor.
* **Pituitary adenoma on MRI**: The presence of a small adenoma on the MRI of the pituitary gland is consistent with Cushing's disease.
* **Clinical presentation**: The patient's symptoms, such as weight gain, purple striae, acne, and muscle weakness, are consistent with Cushing's disease.
* **Hypertension**: The patient's blood pressure is elevated, which is a common finding in Cushing's disease.

The diagnosis of Cushing's disease is further supported by the absence of other findings that might suggest a different diagnosis, such as adrenal Cushing's syndrome. The patient's elevated ACTH levels and the presence of a pituitary adenoma on MRI make adrenal Cushing's syndrome less likely.

**Treatment and Management**

The treatment of Cushing's disease typically involves surgical removal of the pituitary adenoma, followed by radiation therapy if necessary. Medical therapy with glucocorticoid receptor antagonists or other medications may also be used to control the symptoms of Cushing's disease while awaiting surgery or if surgery is not possible.

In this patient's case, the treatment plan would likely involve:

* **Transsphenoidal surgery**: To remove the pituitary adenoma and alleviate the symptoms of Cushing's disease.
* **Glucocorticoid replacement therapy**: To replace the patient's glucocorticoid production, which may be deficient after surgery.
* **Monitoring of cortisol and ACTH levels**: To assess the effectiveness of treatment and adjust the treatment plan as needed.
* **Management of hypertension and other comorbidities**: To reduce the risk of cardiovascular disease and other complications associated with Cushing's disease.","Based on the diagnosis of Cushing's disease, the following additional steps should be taken:

1. **Confirmatory testing**: Perform a high-dose dexamethasone suppression test to confirm the diagnosis of Cushing's disease and rule out other causes of Cushing's syndrome.
2. **Pituitary function tests**: Evaluate the patient's pituitary function by measuring other pituitary hormones, such as thyroid-stimulating hormone (TSH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and growth hormone (GH).
3. **Imaging studies**: Perform additional imaging studies, such as a computed tomography (CT) scan or magnetic resonance imaging (MRI) of the pituitary gland, to further characterize the pituitary adenoma and assess for any potential invasion into surrounding structures.
4. **Ophthalmologic evaluation**: Perform a comprehensive ophthalmologic evaluation to assess for any visual field defects or other ocular complications related to the pituitary adenoma.
5. **Surgical consultation**: Consult with a neurosurgeon to discuss the possibility of surgical removal of the pituitary adenoma.
6. **Medical management**: Initiate medical management with glucocorticoid receptor antagonists, such as ketoconazole or metyrapone, to control the symptoms of Cushing's disease while awaiting surgery.
7. **Monitoring of blood pressure and electrolytes**: Closely monitor the patient's blood pressure and electrolyte levels, as Cushing's disease can cause hypertension and hypokalemia.
8. **Screening for other comorbidities**: Screen the patient for other comorbidities associated with Cushing's disease, such as osteoporosis, diabetes, and cardiovascular disease.
9. **Psychological evaluation**: Perform a psychological evaluation to assess the patient's mental health and provide support for any anxiety, depression, or other psychological symptoms related to Cushing's disease.
10. **Follow-up appointments**: Schedule regular follow-up appointments to monitor the patient's response to treatment and adjust the treatment plan as needed.

**Pre-Surgical Evaluation**

Before surgery, the following evaluations should be performed:

1. **Complete blood count (CBC)**: To assess for any bleeding disorders or anemia.
2. **Electrolyte panel**: To assess for any electrolyte imbalances.
3. **Coagulation studies**: To assess for any coagulopathy.
4. **Echocardiogram**: To assess cardiac function and rule out any cardiac complications.
5. **Pulmonary function tests**: To assess lung function and rule out any respiratory complications.

**Post-Surgical Care**

After surgery, the following care should be provided:

1. **Intensive care unit (ICU) monitoring**: Monitor the patient in the ICU for any potential complications, such as bleeding or respiratory failure.
2. **Pain management**: Provide adequate pain management to ensure the patient's comfort and reduce the risk of complications.
3. **Glucocorticoid replacement therapy**: Initiate glucocorticoid replacement therapy to replace the patient's glucocorticoid production, which may be deficient after surgery.
4. **Monitoring of cortisol and ACTH levels**: Monitor the patient's cortisol and ACTH levels to assess the effectiveness of treatment and adjust the treatment plan as needed.
5. **Follow-up appointments**: Schedule regular follow-up appointments to monitor the patient's recovery and adjust the treatment plan as needed.","{""Score"":2,""Rationale"":""The answer includes Cushing's Syndrome and Cushing's Disease, which match two of the three concepts in the rubric. It does not include Polycystic Ovary Syndrome or Exogenous Steroids, and adds an unrelated diagnosis, so only two points are awarded.""}","{""Score"":4,""Rationale"":""The answer includes correct concepts for Cushing's Disease and Cushing's Syndrome, matching items in the rubric, but does not address PCOS (and lacks the exogenous steroid/OCP history), thus earning 2 points for each of the two covered diagnoses and none for the missing third.""}","{""Score"":2,""Rationale"":""Student correctly mentioned raised ACTH and a pituitary adenoma, matching the Cushing’s Syndrome criteria, but did not provide the required 'no opposing findings' for Cushing’s Disease and omitted the PCOS assessment, resulting in only one of three sections receiving points.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Cushing's Disease and includes the key rubric concepts such as weight gain, purple striae, elevated cortisol, and pituitary adenoma on MRI, matching the high‑scoring example.""}","{""Score"":4,""Rationale"":""The answer includes a dexamethasone suppression test and ACTH measurement, matching two rubric items (2 points each). It does not mention referral to endocrinology, so the third item is missing, resulting in a total of 4 points.""}",14.0
"History Of Present Illness 
A 76-year-old male presents to his primary care physician with complaints of back and thigh pain lasting for 2 weeks. He reports no pain while sitting or lying down, but walking induces severe pain in his lower back, buttocks, and calves. He also feels fatigued and slightly febrile. A referring cardiologist noted recent test results, since the onset of pain, showing a new anemia and azotemia. Notably, a few days prior to the onset of his symptoms, the patient underwent coronary angioplasty, during which he received heparin for 48 hours.
Past Medical History 
Ischemic heart disease had first been diagnosed ten years earlier, at which time a coronary artery bypass procedure was done. 
Physical Examination 
VITALS: 99.6° F.; pulse was 94/min and regular; BP was 110/88 mmHg. 
GEN: Well appearing 
CARDS: There is a grade III/VI apical systolic murmur. 
PULM: Lungs are clear to auscultation bilaterally, no wheezing, or consolidations noted. 
ABD: Soft, non-tender to palpation 
MSK: He does not have tenderness of his spine or pelvis. Spinal mobility is normal, as is the mobility of his hips. Standing is painless; however, pain is experienced in his low back, buttocks and calves within a minute of feeble running in place. The pain disappears shortly after exercise is discontinued. 
EXT: Peripheral pulses were symmetrically reduced, but palpable. The neurological examination was normal. 
SKIN: Patient has a purple, red, lacy rash over his low back and buttocks. 
Laboratory 
WBC of 11.5 x 103 cells /μL; differential of 64% segs, 20% lymphocytes, 3% monocytes, 12% eosinophils and 1% basophil. The hematocrit was 28% and the platelet count was 315 x 103 /μL. The erythrocyte sedimentation rate was 99 mm/h. Urinalysis was normal except for 2+ proteinuria. Serum creatinine was 4.0 mg/dL; sodium was 145 mEq/L; potassium 4.0 mEq/L; chloride 105 mEq/L. SGOT was 27 U/L; GGT was 90 U/L; alkaline phosphatase was 153 U/L.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Aortoiliac Occlusive Disease (Leriche's Syndrome)**: The patient's symptoms of back and thigh pain, especially with walking (claudication), and the presence of a purple, red, lacy rash over his low back and buttocks, suggest a possible diagnosis of aortoiliac occlusive disease. The reduced peripheral pulses and elevated erythrocyte sedimentation rate (ESR) also support this diagnosis.
2. **Cholesterol Crystal Embolization (CCE)**: The patient's recent history of coronary angioplasty and heparin use, followed by the onset of symptoms such as back and thigh pain, fatigue, and febrile illness, raises the possibility of cholesterol crystal embolization. The presence of azotemia (elevated serum creatinine) and proteinuria also supports this diagnosis.
3. **Giant Cell Arteritis (GCA)**: The patient's age, symptoms of back and thigh pain, fatigue, and febrile illness, as well as the elevated ESR and anemia, suggest a possible diagnosis of giant cell arteritis. The presence of a purple, red, lacy rash over his low back and buttocks could be consistent with a GCA-related rash, although this is less common.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Aortoiliac Occlusive Disease (Leriche's Syndrome)**

* Supportive findings:
	+ Claudication (pain in lower back, buttocks, and calves with walking)
	+ Reduced peripheral pulses
	+ Purple, red, lacy rash over low back and buttocks (possibly livedo reticularis)
	+ Elevated erythrocyte sedimentation rate (ESR)
* Risk factors:
	+ Age (76 years old)
	+ History of ischemic heart disease
	+ Smoking (not mentioned, but common in patients with aortoiliac occlusive disease)

**2. Cholesterol Crystal Embolization (CCE)**

* Supportive findings:
	+ Recent coronary angioplasty and heparin use (increased risk of cholesterol crystal embolization)
	+ Onset of symptoms (back and thigh pain, fatigue, and febrile illness) after the procedure
	+ Azotemia (elevated serum creatinine) and proteinuria (suggesting renal involvement)
	+ Anemia and elevated ESR
* Risk factors:
	+ Recent invasive vascular procedure (coronary angioplasty)
	+ Heparin use
	+ Age (76 years old)
	+ History of ischemic heart disease

**3. Giant Cell Arteritis (GCA)**

* Supportive findings:
	+ Age (76 years old)
	+ Elevated ESR (99 mm/h)
	+ Anemia (hematocrit 28%)
	+ Symptoms of back and thigh pain, fatigue, and febrile illness
	+ Presence of a systolic murmur (possibly related to aortitis)
* Risk factors:
	+ Age (76 years old)
	+ Female sex (not applicable in this case, as the patient is male)
	+ History of polymyalgia rheumatica (not mentioned)
	+ Presence of systemic symptoms (fatigue, fever, weight loss)","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Aortoiliac Occlusive Disease (Leriche's Syndrome)**

* Opposing findings:
	+ Normal spinal mobility and no tenderness of the spine or pelvis
	+ Absence of abdominal bruit (a murmur heard over the abdomen, which is often present in aortoiliac occlusive disease)
	+ No significant difference in blood pressure between the upper and lower extremities (not mentioned, but often present in aortoiliac occlusive disease)
* Expected findings not present:
	+ Impotence (a common symptom of Leriche's syndrome, but not mentioned in the patient's history)

**2. Cholesterol Crystal Embolization (CCE)**

* Opposing findings:
	+ The patient's symptoms and laboratory results do not show a clear temporal relationship with the coronary angioplasty and heparin use (the symptoms started a few days after the procedure, but the exact timing is not clear)
	+ The presence of a systolic murmur and proteinuria could suggest other diagnoses, such as giant cell arteritis or renal disease
	+ The patient's renal function is impaired (elevated serum creatinine), but the urinalysis is relatively normal (only 2+ proteinuria)
* Expected findings not present:
	+ Hypertension (often present in patients with CCE, but the patient's blood pressure is relatively normal)
	+ More significant renal dysfunction (e.g., higher serum creatinine, more pronounced proteinuria)
	+ Skin findings typical of CCE, such as livedo reticularis, purpura, or gangrene (although the patient has a purple, red, lacy rash, it is not clear if this is related to CCE)

**3. Giant Cell Arteritis (GCA)**

* Opposing findings:
	+ The patient's symptoms are more localized to the lower back and thighs, whereas GCA often presents with more widespread symptoms, such as headaches, jaw claudication, and visual disturbances
	+ The absence of jaw claudication, scalp tenderness, or visual symptoms (common in GCA)
	+ The patient's laboratory results do not show a clear elevation of inflammatory markers, such as C-reactive protein (not mentioned) or interleukin-6 (not mentioned)
* Expected findings not present:
	+ Temporal artery tenderness or swelling (a common finding in GCA)
	+ Visual symptoms, such as blurred vision, double vision, or loss of vision (not mentioned)
	+ Polymyalgia rheumatica symptoms, such as shoulder or hip pain and stiffness (not mentioned)","Based on the patient's symptoms, laboratory results, and physical examination findings, I would propose the following final diagnosis:

**Cholesterol Crystal Embolization (CCE)**

The patient's recent history of coronary angioplasty and heparin use, followed by the onset of symptoms such as back and thigh pain, fatigue, and febrile illness, raises a strong suspicion for CCE. The presence of azotemia (elevated serum creatinine) and proteinuria also supports this diagnosis, as CCE can cause renal dysfunction.

Additionally, the patient's laboratory results show an elevated erythrocyte sedimentation rate (ESR) and anemia, which are consistent with an inflammatory response and possible renal involvement. The presence of a purple, red, lacy rash over the low back and buttocks could be consistent with livedo reticularis, a skin finding often associated with CCE.

While the patient's symptoms and laboratory results could also be consistent with aortoiliac occlusive disease or giant cell arteritis, the temporal relationship between the coronary angioplasty and the onset of symptoms, combined with the presence of azotemia and proteinuria, makes CCE a more likely diagnosis.

**Rationale for ruling out other diagnoses:**

* Aortoiliac occlusive disease: While the patient's symptoms of claudication and reduced peripheral pulses could suggest aortoiliac occlusive disease, the presence of azotemia and proteinuria, as well as the temporal relationship between the coronary angioplasty and the onset of symptoms, makes CCE a more likely diagnosis.
* Giant cell arteritis: The patient's symptoms and laboratory results do not show a clear pattern of giant cell arteritis, such as temporal artery tenderness, jaw claudication, or visual symptoms. Additionally, the patient's age and sex, while consistent with giant cell arteritis, are not specific enough to make this diagnosis without further evidence.

**Next steps:**

* Confirm the diagnosis of CCE through further testing, such as renal biopsy or imaging studies (e.g., ultrasound, CT angiography)
* Manage the patient's symptoms and prevent further complications, such as renal failure or cardiovascular events
* Consider consulting with a nephrologist or vascular specialist to guide further management and treatment.","Based on the final diagnosis of Cholesterol Crystal Embolization (CCE), here are some additional steps that can be taken:

**Immediate Steps:**

1. **Stop heparin and other anticoagulants**: If the patient is still on heparin or other anticoagulants, consider stopping them to prevent further cholesterol crystal embolization.
2. **Supportive care**: Provide supportive care to manage the patient's symptoms, such as pain management, hydration, and monitoring of vital signs.
3. **Renal function monitoring**: Closely monitor the patient's renal function, including serum creatinine, urine output, and electrolyte levels.

**Diagnostic Steps:**

1. **Renal ultrasound**: Perform a renal ultrasound to evaluate for any signs of renal infarction or other complications.
2. **CT angiography**: Consider performing a CT angiography to evaluate the patient's aorta and renal arteries for any signs of cholesterol crystal embolization.
3. **Biopsy**: Consider performing a renal biopsy to confirm the diagnosis of CCE and to evaluate the extent of renal damage.

**Therapeutic Steps:**

1. **Statins**: Consider starting the patient on statins to reduce the risk of further cholesterol crystal embolization.
2. **Antiplatelet agents**: Consider starting the patient on antiplatelet agents, such as aspirin, to reduce the risk of further cardiovascular events.
3. **Blood pressure management**: Manage the patient's blood pressure to reduce the risk of further renal damage.
4. **Pain management**: Manage the patient's pain with analgesics, such as acetaminophen or opioids, as needed.

**Consultations:**

1. **Nephrology consultation**: Consider consulting with a nephrologist to guide further management and treatment of the patient's renal dysfunction.
2. **Cardiology consultation**: Consider consulting with a cardiologist to guide further management and treatment of the patient's cardiovascular disease.
3. **Vascular surgery consultation**: Consider consulting with a vascular surgeon to evaluate the patient's need for surgical intervention, such as aortic or renal artery stenting.

**Follow-up:**

1. **Close monitoring**: Closely monitor the patient's renal function, cardiovascular status, and overall condition.
2. **Follow-up imaging**: Consider performing follow-up imaging studies, such as CT angiography or renal ultrasound, to evaluate the patient's response to treatment.
3. **Adjust treatment**: Adjust the patient's treatment plan as needed based on their response to treatment and any changes in their condition.","{""Score"":2,""Rationale"":""The answer includes Cholesterol Crystal Embolization, matching 'Cholesterol embolism', and Aortoiliac Occlusive Disease, which is a form of peripheral arterial disease, matching the second rubric item. Giant Cell Arteritis is not listed in the rubric, so only two points are awarded.""}","{""Score"":2,""Rationale"":""The answer includes Cholesterol Crystal Embolization, which matches the rubric's 'Cholesterol embolism' and earns 2 points. The other listed diagnoses (Aortoiliac Occlusive Disease and Giant Cell Arteritis) are not in the rubric, so no points are awarded for them.""}","{""Score"":2,""Rationale"":""The answer only addresses cholesterol embolism, which matches a concept in the high‑scoring example; it does not mention acute interstitial nephritis or peripheral arterial disease, so only 2 of the possible 6 points are earned.""}","{""Score"":2,""Rationale"":""Student correctly identified cholesterol embolism (phrased as Cholesterol Crystal Embolization), matching the high‑scoring answer.""}","{""Score"":2,""Rationale"":""The answer includes consideration of a renal biopsy, matching one rubric item. It lacks arterial ultrasounds of bilateral lower extremities/ABI and urine analysis for casts/eosinophils (though it mentions nephrology consult, the urine analysis component is missing), so only one of three required concepts is present, earning 2 of 6 points.""}",10.0
"History of Present Illness
A 42-year-old male presents with chronic burning pain in his hands and feet, which has worsened over the past year. He has frequent episodes of abdominal cramping and diarrhea. He reports fatigue, decreased exercise tolerance, and intermittent difficulty with vision. He recalls a history of a similar condition in his older brother, who died from kidney failure at the age of 48. 

Past Medical History
The patient has been diagnosed with chronic kidney disease of unknown etiology. He also has a history of hearing loss and occasional headaches. There is a history of diabetes and hypertension. 

Physical Examination
VITALS: BP 150/90 mmHg, pulse 82/min, temperature 98.6°F. 
GEN: Thin, mildly fatigued. 
HEENT: Corneal opacities visible on slit lamp examination. 
CARDIAC: No murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, hepatosplenomegaly noted. 
EXT: Angiokeratomas on the lower abdomen and upper thighs. 
SKIN: No significant rashes. 

Laboratory Results
Serum creatinine is elevated at 2.8 mg/dL. Urinalysis shows 3+ proteinuria with no red blood cells. Alpha-galactosidase A activity in plasma is significantly reduced.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Fabry Disease**: This is a genetic disorder caused by a deficiency of alpha-galactosidase A, which is consistent with the patient's low plasma alpha-galactosidase A activity. The disease can cause chronic burning pain in hands and feet, abdominal cramping, diarrhea, fatigue, and kidney disease, all of which are present in this patient.
2. **Diabetic Neuropathy**: The patient's history of diabetes and symptoms of chronic burning pain in hands and feet, as well as decreased exercise tolerance, could suggest diabetic neuropathy. However, the presence of other symptoms such as corneal opacities, angiokeratomas, and hepatosplenomegaly are not typical of diabetic neuropathy.
3. **Amyloidosis**: This is a group of diseases characterized by the deposition of abnormal proteins (amyloid) in various organs, including the kidneys, liver, and nerves. The patient's symptoms of chronic kidney disease, abdominal cramping, diarrhea, and neuropathic pain could be consistent with amyloidosis. However, the presence of angiokeratomas and corneal opacities are more specific for Fabry disease.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Fabry Disease**

* **Low alpha-galactosidase A activity**: The patient's plasma alpha-galactosidase A activity is significantly reduced, which is a diagnostic hallmark of Fabry disease.
* **Family history**: The patient's older brother died from kidney failure at a young age, which could suggest a genetic disorder such as Fabry disease.
* **Angiokeratomas**: The presence of angiokeratomas on the lower abdomen and upper thighs is a characteristic skin lesion of Fabry disease.
* **Corneal opacities**: The patient's corneal opacities visible on slit lamp examination are consistent with Fabry disease, which can cause corneal clouding.
* **Chronic kidney disease**: The patient's elevated serum creatinine and proteinuria are consistent with Fabry disease, which can cause progressive kidney damage.
* **Neuropathic pain**: The patient's chronic burning pain in hands and feet is a common symptom of Fabry disease, which can cause peripheral neuropathy.

**2. Diabetic Neuropathy**

* **History of diabetes**: The patient has a history of diabetes, which is a major risk factor for diabetic neuropathy.
* **Neuropathic pain**: The patient's chronic burning pain in hands and feet is consistent with diabetic neuropathy.
* **Decreased exercise tolerance**: The patient's decreased exercise tolerance could be related to diabetic neuropathy, which can cause muscle weakness and fatigue.
* **Hypertension**: The patient's hypertension is a common comorbidity with diabetes and could contribute to the development of diabetic neuropathy.

However, the following findings are not typical of diabetic neuropathy:
* Angiokeratomas
* Corneal opacities
* Hepatosplenomegaly
* Low alpha-galactosidase A activity

**3. Amyloidosis**

* **Chronic kidney disease**: The patient's elevated serum creatinine and proteinuria are consistent with amyloidosis, which can cause kidney damage.
* **Hepatosplenomegaly**: The patient's hepatosplenomegaly could be related to amyloidosis, which can cause liver and spleen enlargement.
* **Neuropathic pain**: The patient's chronic burning pain in hands and feet could be related to amyloidosis, which can cause peripheral neuropathy.
* **Family history**: The patient's family history of kidney disease could suggest a genetic form of amyloidosis.

However, the following findings are not typical of amyloidosis:
* Angiokeratomas (more characteristic of Fabry disease)
* Corneal opacities (more characteristic of Fabry disease)
* Low alpha-galactosidase A activity (more characteristic of Fabry disease)","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Fabry Disease**

* **Absence of cardiac involvement**: Fabry disease often causes cardiac involvement, including left ventricular hypertrophy, valvular disease, and arrhythmias. However, the patient's cardiac examination is normal, with no murmurs or gallops.
* **No significant rash**: While angiokeratomas are present, the patient does not have a significant rash, which is sometimes seen in Fabry disease.
* **No reported heat intolerance**: Fabry disease can cause heat intolerance, but the patient does not report this symptom.
* **Normal pulse**: Fabry disease can cause bradycardia, but the patient's pulse is normal at 82/min.

However, the presence of low alpha-galactosidase A activity, angiokeratomas, corneal opacities, and chronic kidney disease still strongly supports the diagnosis of Fabry disease.

**2. Diabetic Neuropathy**

* **Presence of angiokeratomas**: Diabetic neuropathy does not typically cause angiokeratomas, which are more characteristic of Fabry disease.
* **Corneal opacities**: Diabetic neuropathy does not typically cause corneal opacities, which are more characteristic of Fabry disease.
* **Hepatosplenomegaly**: Diabetic neuropathy does not typically cause hepatosplenomegaly, which is more characteristic of amyloidosis or Fabry disease.
* **Low alpha-galactosidase A activity**: Diabetic neuropathy does not typically cause low alpha-galactosidase A activity, which is more characteristic of Fabry disease.
* **Absence of typical diabetic neuropathy symptoms**: The patient does not report typical symptoms of diabetic neuropathy, such as numbness, tingling, or weakness in the hands and feet.

These findings strongly oppose the diagnosis of diabetic neuropathy.

**3. Amyloidosis**

* **Absence of macroglossia**: Amyloidosis can cause macroglossia (enlargement of the tongue), but the patient's tongue is not mentioned as being enlarged.
* **No reported weight loss**: Amyloidosis can cause weight loss, but the patient is described as thin, with no reported weight loss.
* **Normal cardiac examination**: Amyloidosis can cause cardiac involvement, including arrhythmias and heart failure, but the patient's cardiac examination is normal.
* **Low alpha-galactosidase A activity**: Amyloidosis does not typically cause low alpha-galactosidase A activity, which is more characteristic of Fabry disease.
* **Presence of angiokeratomas**: Amyloidosis does not typically cause angiokeratomas, which are more characteristic of Fabry disease.

These findings oppose the diagnosis of amyloidosis, and the presence of low alpha-galactosidase A activity and angiokeratomas strongly supports the diagnosis of Fabry disease.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Fabry Disease**

The diagnosis is supported by the following key findings:

1. **Low alpha-galactosidase A activity**: The patient's plasma alpha-galactosidase A activity is significantly reduced, which is a diagnostic hallmark of Fabry disease.
2. **Angiokeratomas**: The presence of angiokeratomas on the lower abdomen and upper thighs is a characteristic skin lesion of Fabry disease.
3. **Corneal opacities**: The patient's corneal opacities visible on slit lamp examination are consistent with Fabry disease, which can cause corneal clouding.
4. **Chronic kidney disease**: The patient's elevated serum creatinine and proteinuria are consistent with Fabry disease, which can cause progressive kidney damage.
5. **Neuropathic pain**: The patient's chronic burning pain in hands and feet is a common symptom of Fabry disease, which can cause peripheral neuropathy.
6. **Family history**: The patient's older brother died from kidney failure at a young age, which could suggest a genetic disorder such as Fabry disease.

The patient's symptoms and laboratory results are consistent with the classic presentation of Fabry disease, which is a genetic disorder caused by a deficiency of alpha-galactosidase A. The diagnosis of Fabry disease is further supported by the presence of characteristic skin and eye lesions, as well as the patient's family history.

**Treatment and Management**:

The patient should be referred to a specialist in genetic disorders or a nephrologist for further evaluation and management. Treatment options for Fabry disease may include:

1. **Enzyme replacement therapy**: To replace the deficient alpha-galactosidase A enzyme.
2. **Pain management**: To manage the patient's chronic pain.
3. **Kidney disease management**: To slow the progression of kidney disease.
4. **Cardiovascular risk factor management**: To reduce the risk of cardiovascular disease.

Regular follow-up appointments with a healthcare provider will be necessary to monitor the patient's condition and adjust treatment as needed.","Based on the diagnosis of Fabry disease, the following additional steps should be taken:

1. **Genetic testing**: To confirm the diagnosis and identify the specific genetic mutation responsible for the patient's Fabry disease.
2. **Family screening**: To screen the patient's family members for Fabry disease, as it is a genetic disorder that can be inherited.
3. **Enzyme replacement therapy (ERT)**: To replace the deficient alpha-galactosidase A enzyme, which can help to reduce the symptoms of Fabry disease and slow the progression of the disease.
4. **Pain management**: To manage the patient's chronic pain, which can include medications such as gabapentin or pregabalin, as well as other pain management strategies.
5. **Kidney disease management**: To slow the progression of kidney disease, which can include medications such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), as well as other strategies to reduce proteinuria and slow the progression of kidney disease.
6. **Cardiovascular risk factor management**: To reduce the risk of cardiovascular disease, which can include medications such as statins or beta blockers, as well as lifestyle modifications such as a healthy diet and regular exercise.
7. **Regular follow-up appointments**: To monitor the patient's condition and adjust treatment as needed.
8. **Referral to a specialist**: To refer the patient to a specialist in genetic disorders or a nephrologist for further evaluation and management.
9. **Counseling**: To provide the patient with counseling and support to help them cope with the diagnosis and manage the disease.
10. **Education**: To educate the patient and their family members about Fabry disease, its symptoms, and its treatment options.

**Additional tests**:

1. **Echocardiogram**: To evaluate the patient's cardiac function and detect any potential cardiac involvement.
2. **Electrocardiogram (ECG)**: To evaluate the patient's cardiac rhythm and detect any potential arrhythmias.
3. **Nerve conduction studies**: To evaluate the patient's nerve function and detect any potential nerve damage.
4. **Kidney biopsy**: To evaluate the patient's kidney function and detect any potential kidney damage.
5. **Ophthalmologic examination**: To evaluate the patient's eye function and detect any potential eye damage.

**Long-term management**:

1. **Regular monitoring of kidney function**: To detect any potential decline in kidney function and adjust treatment as needed.
2. **Regular monitoring of cardiac function**: To detect any potential decline in cardiac function and adjust treatment as needed.
3. **Regular monitoring of pain**: To adjust pain management strategies as needed.
4. **Regular monitoring of cardiovascular risk factors**: To adjust treatment as needed to reduce the risk of cardiovascular disease.
5. **Regular follow-up appointments**: To monitor the patient's condition and adjust treatment as needed.","{""Score"":1.5,""Rationale"":""The answer includes Fabry Disease (1 mark) and Diabetic Neuropathy (0.5 mark) which are listed in the rubric. It does not include Chronic Kidney Disease secondary to Alport Syndrome, Diabetic Nephropathy, or Polyarteritis Nodosa, and Amyloidosis is not in the rubric, so no points are awarded for those.""}","{""Score"":2,""Rationale"":""The answer includes a detailed description of Fabry Disease that matches the high‑scoring example, earning 2 points. It does not correctly address the other rubric items (CKD secondary to Alport Syndrome, Diabetic Related Complications, Polyarteritis Nodosa) or provide the required key concepts for those diagnoses, so no additional points are awarded.""}","{""Score"": 2, ""Rationale"": ""The answer correctly identified opposing findings for Diabetes related complications (angiokeratomas and corneal findings) matching the rubric, but provided incorrect or missing opposing findings for Fabry Disease, CKD secondary to Alport, and Polyarteritis Nodosa, resulting in only one of the four 2‑point items being met.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Fabry Disease and lists the key clinical features (burning pain, angiokeratomas, corneal opacities, family history, reduced alpha‑galactosidase A activity) matching the high‑scoring example.""}","{""Score"":6,""Rationale"":""Student includes all three rubric concepts: genetic testing, enzyme replacement therapy, and monitoring renal/kidney function, each earning 2 points.""}",13.5
"History of Present Illness
A 55-year-old female presents with a 3-month history of progressive difficulty swallowing, drooping of her eyelids, and muscle weakness. She reports that her symptoms are worse by the end of the day and improve with rest. She has also noticed difficulty speaking and has frequent choking episodes when drinking liquids. There is no associated pain, and she denies any other systemic symptoms.

  Past Medical History
She has no significant medical history but was diagnosed with hypothyroidism 5 years ago and has been on levothyroxine since then. Family history is unremarkable.

  Physical Examination
VITALS: BP 130/80 mmHg, pulse 75/min, temperature 98.7°F. 
GEN: Well-appearing, no distress. 
HEENT: Ptosis noted in both eyelids, worse on the right side. 
PULM: Clear to auscultation bilaterally. 
NEURO: Proximal muscle weakness
EXT: No edema

  Laboratory Results
Acetylcholine receptor antibodies are positive. Serum creatine kinase (CK) is normal.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Myasthenia Gravis**: The patient's symptoms of progressive difficulty swallowing, drooping of eyelids (ptosis), muscle weakness, and worsening of symptoms by the end of the day are consistent with myasthenia gravis. The presence of acetylcholine receptor antibodies also supports this diagnosis.
2. **Amyotrophic Lateral Sclerosis (ALS)**: Although less likely, ALS could be considered due to the patient's symptoms of progressive muscle weakness, difficulty speaking, and swallowing. However, the presence of acetylcholine receptor antibodies and the pattern of symptom worsening and improvement with rest are not typical of ALS.
3. **Lambert-Eaton Myasthenic Syndrome (LEMS)**: This rare autoimmune disorder could be considered as a possible diagnosis, as it also presents with muscle weakness, ptosis, and swallowing difficulties. However, LEMS is often associated with other systemic symptoms, such as autonomic dysfunction, and the patient's laboratory results would need to be further evaluated to support this diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Myasthenia Gravis (MG)**

* **Supporting findings:**
	+ Positive acetylcholine receptor antibodies: This is a specific and sensitive test for MG, and the presence of these antibodies is a strong indicator of the disease.
	+ Ptosis (drooping of eyelids) and proximal muscle weakness: These are classic symptoms of MG, and the patient's presentation is consistent with this diagnosis.
	+ Worsening of symptoms by the end of the day and improvement with rest: This pattern of symptom fluctuation is typical of MG.
	+ Difficulty swallowing (dysphagia) and speaking (dysarthria): These symptoms are also common in MG, particularly in more advanced cases.
* **Risk factors:**
	+ Female sex: MG is more common in women, particularly in the 20-40 age range, but can occur at any age.
	+ Hypothyroidism: There is an association between MG and other autoimmune disorders, including hypothyroidism, which the patient has been diagnosed with.

**2. Amyotrophic Lateral Sclerosis (ALS)**

* **Supporting findings:**
	+ Progressive muscle weakness: This is a hallmark symptom of ALS, and the patient's presentation is consistent with this diagnosis.
	+ Difficulty speaking (dysarthria) and swallowing (dysphagia): These symptoms can occur in ALS, particularly in more advanced cases.
* **Risk factors:**
	+ Age: The patient is 55 years old, which is within the typical age range for ALS (50-70 years).
	+ None of the other typical risk factors for ALS, such as family history or prior radiation exposure, are mentioned in the patient's history.
* **However, note that:**
	+ The presence of acetylcholine receptor antibodies is not typical of ALS.
	+ The pattern of symptom worsening and improvement with rest is not typical of ALS, which usually progresses in a more linear fashion.

**3. Lambert-Eaton Myasthenic Syndrome (LEMS)**

* **Supporting findings:**
	+ Proximal muscle weakness: This is a common symptom of LEMS, and the patient's presentation is consistent with this diagnosis.
	+ Ptosis (drooping of eyelids): This symptom can occur in LEMS, although it is less common than in MG.
* **Risk factors:**
	+ None of the typical risk factors for LEMS, such as smoking or a history of cancer, are mentioned in the patient's history.
* **However, note that:**
	+ The presence of acetylcholine receptor antibodies is more typical of MG than LEMS, which is usually associated with voltage-gated calcium channel antibodies.
	+ The patient's symptoms and laboratory results do not strongly support LEMS, making this diagnosis less likely.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Myasthenia Gravis (MG)**

* **Opposing findings:**
	+ Normal serum creatine kinase (CK) levels: Elevated CK levels can occur in MG, particularly during exacerbations, but normal levels do not rule out the diagnosis.
	+ No mention of other typical MG symptoms, such as double vision (diplopia) or facial weakness: While these symptoms can occur in MG, their absence does not strongly oppose the diagnosis.
* **Expected findings that are not present:**
	+ No mention of respiratory muscle involvement: MG can affect the respiratory muscles, leading to respiratory failure, but this is not mentioned in the patient's history.
	+ No mention of other autoimmune disorders: MG is often associated with other autoimmune disorders, such as thyroid disease (which the patient has) or rheumatoid arthritis, but no other autoimmune disorders are mentioned.

**2. Amyotrophic Lateral Sclerosis (ALS)**

* **Opposing findings:**
	+ Positive acetylcholine receptor antibodies: This is a specific test for MG and is not typically positive in ALS.
	+ Worsening of symptoms by the end of the day and improvement with rest: This pattern of symptom fluctuation is not typical of ALS, which usually progresses in a more linear fashion.
	+ No mention of upper motor neuron signs: ALS is characterized by a combination of upper and lower motor neuron signs, such as hyperreflexia, spasticity, and muscle atrophy, but these are not mentioned in the patient's history.
* **Expected findings that are not present:**
	+ No mention of fasciculations: Fasciculations are a common finding in ALS, particularly in the tongue and limbs, but are not mentioned in the patient's history.
	+ No mention of muscle atrophy: ALS is characterized by progressive muscle atrophy, but this is not mentioned in the patient's history.

**3. Lambert-Eaton Myasthenic Syndrome (LEMS)**

* **Opposing findings:**
	+ Positive acetylcholine receptor antibodies: This is a specific test for MG and is not typically positive in LEMS, which is usually associated with voltage-gated calcium channel antibodies.
	+ No mention of autonomic dysfunction: LEMS is often associated with autonomic dysfunction, such as dry mouth, impotence, or orthostatic hypotension, but these symptoms are not mentioned in the patient's history.
* **Expected findings that are not present:**
	+ No mention of cancer: LEMS is often associated with underlying cancer, particularly small cell lung cancer, but no cancer history is mentioned in the patient's history.
	+ No mention of other typical LEMS symptoms, such as areflexia or proximal muscle weakness that improves with repeated use: While the patient has proximal muscle weakness, the pattern of symptom improvement with repeated use is not mentioned.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Myasthenia Gravis (MG)**

The diagnosis of MG is supported by the following:

1. **Positive acetylcholine receptor antibodies**: This is a specific and sensitive test for MG, and the presence of these antibodies is a strong indicator of the disease.
2. **Classic symptoms of MG**: The patient's symptoms of progressive difficulty swallowing, drooping of eyelids (ptosis), muscle weakness, and worsening of symptoms by the end of the day are consistent with MG.
3. **Pattern of symptom fluctuation**: The patient's symptoms worsen by the end of the day and improve with rest, which is a typical pattern of symptom fluctuation in MG.
4. **Physical examination findings**: The patient's physical examination findings, including ptosis and proximal muscle weakness, are consistent with MG.

While the patient's symptoms could also be consistent with other diagnoses, such as ALS or LEMS, the presence of positive acetylcholine receptor antibodies and the classic symptoms of MG make this diagnosis the most likely.

**Treatment and management**:

The patient should be referred to a neurologist for further evaluation and management. Treatment for MG typically involves:

1. **Medications**: Acetylcholinesterase inhibitors, such as pyridostigmine, to improve muscle strength and reduce symptoms.
2. **Immunosuppressive therapy**: Corticosteroids, such as prednisone, to reduce the immune system's attack on the acetylcholine receptors.
3. **Thymectomy**: Surgical removal of the thymus gland, which can help to reduce symptoms and improve treatment response in some patients.

**Prognosis**:

The prognosis for MG is generally good, with most patients experiencing significant improvement in symptoms with treatment. However, the disease can be unpredictable, and some patients may experience exacerbations or remissions. Regular follow-up with a neurologist and adherence to treatment are essential to manage the disease and prevent complications.","Based on the diagnosis of Myasthenia Gravis (MG), the following additional steps should be taken:

**Immediate Steps:**

1. **Medication management**: Initiate treatment with acetylcholinesterase inhibitors, such as pyridostigmine, to improve muscle strength and reduce symptoms.
2. **Corticosteroids**: Consider starting corticosteroids, such as prednisone, to reduce the immune system's attack on the acetylcholine receptors.
3. **Monitor vital signs**: Closely monitor the patient's vital signs, including respiratory rate, to ensure that they do not deteriorate.

**Short-term Steps:**

1. **Thymus imaging**: Order a chest computed tomography (CT) scan or magnetic resonance imaging (MRI) to evaluate the thymus gland for any abnormalities, such as thymoma.
2. **Electrophysiological testing**: Perform electromyography (EMG) and nerve conduction studies (NCS) to assess the patient's muscle and nerve function.
3. **Blood tests**: Monitor the patient's blood tests, including complete blood count (CBC), electrolyte panel, and liver function tests, to ensure that they do not have any underlying conditions that may be contributing to their symptoms.

**Long-term Steps:**

1. **Thymectomy**: Consider surgical removal of the thymus gland, particularly if the patient has a thymoma or if their symptoms are not well-controlled with medication.
2. **Immunosuppressive therapy**: Continue immunosuppressive therapy, such as corticosteroids or azathioprine, to reduce the immune system's attack on the acetylcholine receptors.
3. **Regular follow-up**: Schedule regular follow-up appointments with a neurologist to monitor the patient's symptoms, adjust their medication as needed, and prevent complications.
4. **Lifestyle modifications**: Educate the patient on lifestyle modifications, such as getting regular exercise, eating a balanced diet, and avoiding stress, to help manage their symptoms and improve their overall quality of life.

**Specialized Care:**

1. **Neurology consultation**: Refer the patient to a neurologist who specializes in MG for ongoing care and management.
2. **Multidisciplinary care team**: Assemble a multidisciplinary care team, including a neurologist, primary care physician, and other healthcare professionals, to provide comprehensive care and support to the patient.

By taking these additional steps, the patient can receive the best possible care and management for their MG, and their symptoms can be effectively controlled to improve their quality of life.","{""Score"":2,""Rationale"":""The answer includes Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome, which match two of the three rubric items. It does not include Hypothyroid Myopathy, instead listing ALS, which is not in the rubric, so only 2 points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Myasthenia Gravis with the key findings listed in the rubric, earning 2 points. It does not provide the required LEMS characteristics (improvement with activity, specific antibody testing, EMG facilitation) and omits any discussion of Hypothyroid Myopathy, so no points are awarded for those sections.""}","{""Score"":0,""Rationale"":""The answer does not mention any of the specific opposing findings listed in the rubric for Myasthenia Gravis, Lambert-Eaton Myasthenic Syndrome, or Hypothyroid Myopathy, and includes unrelated diagnoses; therefore no points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Myasthenia Gravis and includes the key concepts from the high‑scoring example (ptosis, bulbar weakness/dysphagia, fatigue improving with rest, positive acetylcholine receptor antibodies). All required elements are present, earning full credit.""}","{""Score"":2,""Rationale"":""The answer includes thymus imaging (CT/MRI of chest) matching one rubric item, but omits the Edrophonium test and thyroid function assessment, so only 2 of 6 points are earned.""}",8.0
"History of Present Illness
A 41-year-old male presents with a 4-week history of chronic sinus congestion, bloody nasal discharge, and persistent cough with hemoptysis. He also complains of joint pain and swelling in both knees and ankles. He reports unintentional weight loss of 8 kg over the last 2 months. He denies any recent trauma, travel, or exposure to sick contacts.

  Past Medical History
The patient has no significant medical history but was previously healthy. He has no known drug allergies and does not smoke or drink alcohol.

  Physical Examination
VITALS: BP 120/78 mmHg, pulse 88/min, temperature 99.2°F. 
GEN: Well-appearing but fatigued. 
HEENT: Nasal mucosal ulcerations, bloody discharge from both nostrils. 
PULM: Bilateral rales in the lungs. 
ABD: Soft, non-tender. 
EXT: Swelling in both knees and ankles, with mild erythema. 
SKIN: No rashes.

  Laboratory Results
WBC count is 12.8 x 103/μL, with a mild left shift. ESR is elevated at 75 mm/h. Serum creatinine is 1.5 mg/dL, and urinalysis shows 1+ proteinuria with RBC casts. c-ANCA is positive. Chest CT shows multiple nodular lung infiltrates and cavities.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**: This is a type of vasculitis that affects small- and medium-sized blood vessels, and is characterized by the presence of c-ANCA. The patient's symptoms, such as sinus congestion, bloody nasal discharge, hemoptysis, and renal involvement (elevated serum creatinine and proteinuria with RBC casts), are consistent with GPA.
2. **Sarcoidosis**: This is a systemic inflammatory disease that can affect multiple organs, including the lungs, skin, and joints. The patient's symptoms, such as joint pain and swelling, lung infiltrates, and skin lesions (although not present in this case), are consistent with sarcoidosis. However, the presence of c-ANCA and the specific pattern of organ involvement make GPA a more likely diagnosis.
3. **Polyarteritis Nodosa (PAN)**: This is a type of vasculitis that affects medium-sized blood vessels, and can cause a range of symptoms, including joint pain, renal involvement, and lung disease. However, PAN is typically associated with p-ANCA, rather than c-ANCA, and the patient's symptoms and laboratory results are more consistent with GPA.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

* **Supporting findings:**
	+ Positive c-ANCA: This is a highly specific marker for GPA, and is present in the majority of patients with active disease.
	+ Nasal mucosal ulcerations and bloody discharge: These are common manifestations of GPA, and are due to the granulomatous inflammation and vasculitis that characterize the disease.
	+ Hemoptysis and lung infiltrates: GPA can cause lung disease, including nodular infiltrates and cavities, which are seen on the chest CT.
	+ Renal involvement (elevated serum creatinine and proteinuria with RBC casts): GPA can cause rapidly progressive glomerulonephritis, which is a common cause of renal failure in these patients.
	+ Systemic symptoms (weight loss, fatigue): These are common in GPA, and are due to the systemic nature of the disease.
* **Risk factors:**
	+ Upper respiratory tract symptoms (sinus congestion, nasal discharge): These are common in GPA, and can be the initial presentation of the disease.
	+ Male sex: GPA is slightly more common in males than females.

**2. Sarcoidosis**

* **Supporting findings:**
	+ Bilateral lung infiltrates: Sarcoidosis can cause lung disease, including bilateral infiltrates and nodules.
	+ Joint pain and swelling: Sarcoidosis can cause arthritis, which is a common manifestation of the disease.
	+ Systemic symptoms (weight loss, fatigue): These are common in sarcoidosis, and are due to the systemic nature of the disease.
* **Risk factors:**
	+ Age: Sarcoidosis is most common in adults between the ages of 20 and 40.
	+ Sex: Sarcoidosis is slightly more common in females than males.
	+ However, the presence of c-ANCA and the specific pattern of organ involvement make GPA a more likely diagnosis.

**3. Polyarteritis Nodosa (PAN)**

* **Supporting findings:**
	+ Joint pain and swelling: PAN can cause arthritis, which is a common manifestation of the disease.
	+ Renal involvement (elevated serum creatinine and proteinuria): PAN can cause renal disease, including glomerulonephritis and vasculitis.
	+ Systemic symptoms (weight loss, fatigue): These are common in PAN, and are due to the systemic nature of the disease.
* **Risk factors:**
	+ Hepatitis B infection: PAN is associated with hepatitis B infection, although this is not present in the patient's history.
	+ However, the presence of c-ANCA and the specific pattern of organ involvement make GPA a more likely diagnosis, as PAN is typically associated with p-ANCA.","Here are the findings that oppose each of the possible diagnoses, or findings that were expected but not present:

**1. Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

* **Opposing findings:**
	+ Absence of skin lesions: GPA can cause skin lesions, including purpura, ulcers, and nodules, but these are not present in this patient.
	+ Normal blood pressure: GPA can cause renal disease, which can lead to hypertension, but the patient's blood pressure is normal.
* **Expected findings that are not present:**
	+ Eye involvement: GPA can cause eye disease, including conjunctivitis, scleritis, and uveitis, but there is no mention of eye symptoms in the patient's history.
	+ Ear involvement: GPA can cause ear disease, including hearing loss and vertigo, but there is no mention of ear symptoms in the patient's history.
	+ Gastrointestinal symptoms: GPA can cause gastrointestinal symptoms, including abdominal pain and diarrhea, but these are not present in the patient's history.

**2. Sarcoidosis**

* **Opposing findings:**
	+ Presence of c-ANCA: Sarcoidosis is not typically associated with c-ANCA, which is a marker for GPA.
	+ Presence of renal disease (elevated serum creatinine and proteinuria with RBC casts): Sarcoidosis can cause renal disease, but it is less common than in GPA, and the pattern of renal involvement is different.
	+ Presence of hemoptysis: Sarcoidosis can cause lung disease, but hemoptysis is less common than in GPA.
* **Expected findings that are not present:**
	+ Lymphadenopathy: Sarcoidosis can cause lymphadenopathy, but there is no mention of this in the patient's history.
	+ Skin lesions: Sarcoidosis can cause skin lesions, including erythema nodosum and lupus pernio, but these are not present in the patient's history.
	+ Neurological symptoms: Sarcoidosis can cause neurological symptoms, including seizures and neuropathy, but these are not present in the patient's history.

**3. Polyarteritis Nodosa (PAN)**

* **Opposing findings:**
	+ Presence of c-ANCA: PAN is typically associated with p-ANCA, rather than c-ANCA.
	+ Presence of granulomatous inflammation (nasal mucosal ulcerations and lung infiltrates): PAN is a necrotizing vasculitis, rather than a granulomatous disease.
	+ Presence of renal disease (elevated serum creatinine and proteinuria with RBC casts): PAN can cause renal disease, but the pattern of involvement is different than in GPA.
* **Expected findings that are not present:**
	+ Abdominal pain: PAN can cause abdominal pain due to mesenteric vasculitis, but this is not present in the patient's history.
	+ Neuropathy: PAN can cause neuropathy due to vasculitis of the peripheral nerves, but this is not present in the patient's history.
	+ Testicular pain: PAN can cause testicular pain due to vasculitis of the testicular arteries, but this is not present in the patient's history.","Based on the patient's symptoms, laboratory results, and physical examination, the final diagnosis is:

**Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

The diagnosis is supported by the following key findings:

* Positive c-ANCA, which is a highly specific marker for GPA
* Nasal mucosal ulcerations and bloody discharge, which are common manifestations of GPA
* Hemoptysis and lung infiltrates, which are consistent with GPA
* Renal involvement (elevated serum creatinine and proteinuria with RBC casts), which is a common cause of renal failure in GPA
* Systemic symptoms (weight loss, fatigue), which are common in GPA

The patient's symptoms and laboratory results are consistent with the American College of Rheumatology (ACR) criteria for GPA, which include:

* Nasal or oral inflammation
* Abnormal chest radiograph
* Hematuria or red blood cell casts
* Granulomatous inflammation on biopsy

The patient's positive c-ANCA and granulomatous inflammation on biopsy (if performed) would confirm the diagnosis of GPA.

Treatment for GPA typically involves immunosuppressive therapy, such as cyclophosphamide or rituximab, in combination with glucocorticoids. The goal of treatment is to induce remission and prevent organ damage.

It is essential to note that GPA is a serious and potentially life-threatening disease, and prompt treatment is necessary to prevent complications and improve outcomes.","Based on the final diagnosis of Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA), the following additional steps should be taken:

1. **Confirmatory biopsy**: A biopsy of the affected tissue (e.g., lung, kidney, or nasal mucosa) should be performed to confirm the diagnosis of GPA and to rule out other conditions.
2. **Imaging studies**: Additional imaging studies, such as a chest CT or MRI, may be necessary to evaluate the extent of disease and to monitor response to treatment.
3. **Laboratory tests**: Regular laboratory tests, including complete blood counts, electrolyte panels, and renal function tests, should be performed to monitor the patient's response to treatment and to detect any potential side effects.
4. **Infectious disease screening**: The patient should be screened for infectious diseases, such as hepatitis B and C, and HIV, as these can increase the risk of complications and affect treatment.
5. **Ophthalmologic evaluation**: The patient should undergo an ophthalmologic evaluation to rule out eye involvement, which is common in GPA.
6. **ENT evaluation**: The patient should undergo an ENT evaluation to assess the extent of nasal and sinus involvement and to rule out other conditions.
7. **Pulmonary function tests**: Pulmonary function tests, such as spirometry and diffusion capacity, should be performed to assess the patient's lung function and to monitor response to treatment.
8. **Renal function monitoring**: The patient's renal function should be closely monitored, as GPA can cause rapidly progressive glomerulonephritis.
9. **Medication management**: The patient should be started on immunosuppressive therapy, such as cyclophosphamide or rituximab, in combination with glucocorticoids, to induce remission and prevent organ damage.
10. **Follow-up appointments**: The patient should have regular follow-up appointments with a rheumatologist or nephrologist to monitor response to treatment and to adjust the treatment plan as needed.

Additionally, the following precautions should be taken:

* **Avoid exposure to infections**: The patient should avoid exposure to infections, such as influenza and pneumonia, as these can exacerbate GPA.
* **Avoid certain medications**: The patient should avoid certain medications, such as non-steroidal anti-inflammatory drugs (NSAIDs), which can worsen renal function.
* **Monitor for side effects**: The patient should be monitored for side effects of immunosuppressive therapy, such as bone marrow suppression, infection, and malignancy.

By taking these additional steps, the patient's condition can be effectively managed, and the risk of complications can be minimized.","{""Score"":1,""Rationale"":""Only the first diagnosis matches a rubric item (Granulomatosis with Polyangiitis/Wegener's). The other two diagnoses (Sarcoidosis and Polyarteritis Nodosa) are not listed in the rubric, so no points awarded for them.""}","{""Score"":2,""Rationale"":""Student correctly identified GPA with matching findings (c-ANCA, nasal ulcerations, hemoptysis, lung infiltrates, renal involvement), earning 2 points. No mention of RA or infectious causes as described in the rubric, so no points for those categories.""}","{""Score"":0,""Rationale"":""The answer discusses Wegener's Granulomatosis, Sarcoidosis, and Polyarteritis Nodosa, which do not match any of the diagnoses (GPA, RA, Infectious causes) specified in the rubric; therefore no points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Granulomatosis with Polyangiitis (GPA) and provides supporting clinical features consistent with the high‑scoring example, thus meeting the rubric criteria for full credit.""}","{""Score"":2,""Rationale"":""The answer includes referral to a rheumatologist for management and immunosuppressive therapy, matching item 2. It does not mention serial urine analysis for renal monitoring nor joint imaging, so only 2 of the 6 possible points are earned.""}",7.0
"History of Present Illness
A 32-year-old female presents with a 3-day history of severe abdominal pain, nausea, vomiting, and constipation. The pain is intermittent, severe, and located in the lower abdomen, associated with dark urine and pale stools. She has also noted difficulty with muscle weakness, especially in her legs. The pain started after she began taking oral contraceptives for the past 2 weeks. She has had similar episodes in the past, but they were less intense and occurred about once a year.

  Past Medical History
She has a history of irregular menstrual cycles and has been using oral contraceptives for 2 months to regulate them. There is no significant family history of bleeding or liver disorders. She has been generally healthy, with no history of liver disease or significant medications prior to the oral contraceptive use.

  Physical Examination
VITALS: BP 120/75 mmHg, pulse 85/min, temperature 98.9°F. 
GEN: Appears in moderate distress, pale. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Diffuse tenderness to palpation in the lower abdomen with no rebound tenderness. EXT: Muscle weakness in the lower extremities, especially when standing. 
SKIN: No rashes, but urine is dark brown in color.

  Laboratory Results
Urine porphyrin levels are markedly elevated. Serum sodium is low at 130 mEq/L, and liver function tests are normal. Hemoglobin is 11.3 g/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Acute Intermittent Porphyria (AIP)**: The patient's symptoms of severe abdominal pain, nausea, vomiting, constipation, and muscle weakness, along with the elevated urine porphyrin levels, are consistent with AIP. The use of oral contraceptives may have triggered an acute attack.
2. **Porphyria Cutanea Tarda (PCT)**: Although PCT typically presents with skin manifestations, the patient's elevated urine porphyrin levels and abdominal symptoms could suggest a diagnosis of PCT. However, the absence of skin lesions and the presence of acute abdominal symptoms make AIP a more likely diagnosis.
3. **Variegate Porphyria (VP)**: VP is another type of porphyria that can present with acute abdominal symptoms, muscle weakness, and elevated urine porphyrin levels. The patient's symptoms and laboratory results could be consistent with VP, although the absence of skin lesions and the specific pattern of porphyrin elevation would need to be further evaluated to confirm this diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Intermittent Porphyria (AIP)**

* **Severe abdominal pain**: AIP is characterized by recurrent episodes of severe abdominal pain, which is consistent with the patient's symptoms.
* **Elevated urine porphyrin levels**: The patient's urine porphyrin levels are markedly elevated, which is a hallmark of AIP.
* **Muscle weakness**: The patient's muscle weakness, especially in the lower extremities, is a common symptom of AIP.
* **Triggered by oral contraceptives**: The patient's symptoms started after she began taking oral contraceptives, which are known to be a potential trigger for AIP attacks.
* **Normal liver function tests**: AIP is not typically associated with liver dysfunction, which is consistent with the patient's normal liver function tests.
* **History of similar episodes**: The patient has a history of similar episodes, although less intense, which suggests a recurrent condition like AIP.

**2. Porphyria Cutanea Tarda (PCT)**

* **Elevated urine porphyrin levels**: While the patient's urine porphyrin levels are elevated, PCT is typically associated with a specific pattern of porphyrin elevation, which would need to be further evaluated.
* **Risk factors for PCT**: Although not explicitly mentioned, risk factors for PCT include hepatitis C, HIV, and estrogen use (e.g., oral contraceptives). The patient's use of oral contraceptives could be a potential risk factor.
* **However, lack of skin manifestations**: PCT is typically characterized by skin lesions, such as blisters, erosions, and hypertrichosis, which are not present in this patient.

**3. Variegate Porphyria (VP)**

* **Elevated urine porphyrin levels**: The patient's urine porphyrin levels are elevated, which is consistent with VP.
* **Abdominal symptoms**: VP can present with acute abdominal symptoms, including pain, nausea, and vomiting, which are consistent with the patient's symptoms.
* **Muscle weakness**: The patient's muscle weakness is also consistent with VP.
* **Triggered by oral contraceptives**: Like AIP, VP can be triggered by oral contraceptives, which the patient recently started taking.
* **However, lack of skin manifestations**: VP can also present with skin manifestations, such as blistering and photosensitivity, which are not present in this patient.

Overall, the patient's symptoms and laboratory results are most consistent with AIP, although VP is also a possible diagnosis. PCT is less likely due to the lack of skin manifestations.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Intermittent Porphyria (AIP)**

* **Lack of neurological symptoms**: AIP is often associated with neurological symptoms such as seizures, psychosis, and peripheral neuropathy, which are not present in this patient.
* **Normal mental status**: Patients with AIP often exhibit altered mental status, including anxiety, depression, and confusion, which is not mentioned in the patient's presentation.
* **No history of neuropathic pain**: AIP is often characterized by neuropathic pain, which is not described in the patient's symptoms.
* **Hemoglobin level is not severely low**: While the patient's hemoglobin is slightly low (11.3 g/dL), it is not severely low, which is sometimes seen in AIP due to hemolysis.

**2. Porphyria Cutanea Tarda (PCT)**

* **Lack of skin manifestations**: PCT is characterized by skin lesions, such as blisters, erosions, and hypertrichosis, which are not present in this patient.
* **No history of liver disease**: PCT is often associated with liver disease, such as hepatitis C or cirrhosis, which is not mentioned in the patient's past medical history.
* **Normal liver function tests**: While the patient's liver function tests are normal, PCT is often associated with abnormal liver function tests, such as elevated transaminases.
* **No history of alcohol use**: PCT is often associated with alcohol use, which is not mentioned in the patient's social history.

**3. Variegate Porphyria (VP)**

* **Lack of skin manifestations**: Like PCT, VP can present with skin manifestations, such as blistering and photosensitivity, which are not present in this patient.
* **No history of photosensitivity**: VP is often associated with photosensitivity, which is not mentioned in the patient's symptoms.
* **Normal liver function tests**: While the patient's liver function tests are normal, VP can be associated with abnormal liver function tests, such as elevated transaminases.
* **No family history of porphyria**: VP is often inherited in an autosomal dominant pattern, and a family history of porphyria would be expected, but is not mentioned in the patient's past medical history.

Overall, while each diagnosis has some opposing findings, AIP remains the most likely diagnosis based on the patient's symptoms and laboratory results.","Based on the patient's symptoms, laboratory results, and the analysis of the possible diagnoses, I would make a final diagnosis of:

**Acute Intermittent Porphyria (AIP)**

The patient's symptoms of severe abdominal pain, nausea, vomiting, constipation, and muscle weakness, along with the elevated urine porphyrin levels, are consistent with AIP. The use of oral contraceptives as a potential trigger for the attack also supports this diagnosis. While there are some opposing findings, such as the lack of neurological symptoms and normal mental status, the overall clinical presentation and laboratory results are most consistent with AIP.

**Rationale:**

* The patient's symptoms are consistent with an acute porphyria attack, and AIP is the most common type of acute porphyria.
* The elevated urine porphyrin levels are a hallmark of AIP, and the patient's levels are markedly elevated.
* The use of oral contraceptives as a potential trigger for the attack is consistent with AIP, as estrogen can induce the enzyme aminolevulinic acid synthase, leading to an increase in porphyrin production.
* While other types of porphyria, such as VP, can also present with similar symptoms, the lack of skin manifestations and the specific pattern of porphyrin elevation make AIP the most likely diagnosis.

**Next Steps:**

* Confirm the diagnosis with further testing, such as genetic analysis or measurement of specific porphyrin metabolites.
* Discontinue the use of oral contraceptives and consider alternative methods of birth control.
* Provide supportive care, including pain management and hydration, to help manage the patient's symptoms.
* Consider referring the patient to a specialist in porphyria or a genetic counselor to discuss the implications of the diagnosis and provide guidance on management and prevention of future attacks.","Based on the final diagnosis of Acute Intermittent Porphyria (AIP), here are some additional steps that can be taken:

**Immediate Management:**

1. **Pain management**: Provide adequate pain control using medications such as morphine or other opioids, as AIP can cause severe abdominal pain.
2. **Hydration**: Ensure the patient is well-hydrated to help manage symptoms and prevent complications.
3. **Rest**: Encourage the patient to rest and avoid strenuous activities to help manage symptoms.
4. **Monitoring**: Closely monitor the patient's vital signs, including blood pressure, pulse, and temperature, and watch for signs of complications such as respiratory failure or cardiac arrhythmias.

**Diagnostic Confirmation:**

1. **Genetic testing**: Confirm the diagnosis of AIP with genetic testing to identify the specific mutation responsible for the condition.
2. **Porphyrin metabolite measurement**: Measure the levels of specific porphyrin metabolites, such as aminolevulinic acid (ALA) and porphobilinogen (PBG), to confirm the diagnosis and monitor the patient's response to treatment.
3. **Urinary porphyrin screening**: Perform a urinary porphyrin screen to detect the presence of porphyrins and their metabolites.

**Long-term Management:**

1. **Avoid triggers**: Identify and avoid triggers that can precipitate AIP attacks, such as certain medications, hormonal changes, and stress.
2. **Hormonal management**: Consider hormonal management, such as using hormonal contraceptives or hormone replacement therapy, to regulate menstrual cycles and prevent AIP attacks.
3. **Nutritional counseling**: Provide nutritional counseling to ensure the patient is getting adequate nutrients, particularly those that are important for porphyrin metabolism, such as vitamin B6 and magnesium.
4. **Regular follow-up**: Schedule regular follow-up appointments to monitor the patient's condition, adjust treatment as needed, and provide ongoing support and education.

**Specialist Referral:**

1. **Porphyria specialist**: Refer the patient to a specialist in porphyria, such as a geneticist or a hepatologist, for further evaluation and management.
2. **Genetic counseling**: Refer the patient to a genetic counselor to discuss the implications of the diagnosis, provide guidance on family planning, and offer support and resources.

**Patient Education:**

1. **Disease education**: Educate the patient about AIP, its symptoms, and its management to empower them to take an active role in their care.
2. **Trigger avoidance**: Educate the patient on how to avoid triggers and manage stress to prevent AIP attacks.
3. **Emergency planning**: Develop an emergency plan with the patient, including what to do in case of an AIP attack, and provide them with a medical alert card or bracelet.","{""Score"":0.5,""Rationale"":""Only Acute Intermittent Porphyria (AIP) matches the rubric; the other two diagnoses (Porphyria Cutanea Tarda and Variegate Porphyria) are not listed, so no points for them.""}","{""Score"":1,""Rationale"":""Student correctly identified Acute Intermittent Porphyria with matching features from the rubric, but omitted the other two required diagnoses (Cholecystitis/Gallstones and IBS), so only partial credit is awarded.""}","{""Score"":0,""Rationale"":""Student's answer does not align with any of the concepts or arguments presented in the high‑scoring example. They provided opposing findings for AIP, which contradicts the rubric’s statement of no opposing findings, and omitted any discussion of Gallstones/Cholecystitis and IBS, resulting in zero points.""}","{""Score"": 14.5, ""Rationale"": ""Student correctly identified Acute Intermittent Porphyria (AIP) and provided matching clinical features and lab findings as in the high scoring example, thus earning full credit.""}","{""Score"":1,""Rationale"":""The answer includes genetic testing, matching one rubric item. It does not mention IV glucose or hematin infusion, nor discontinuation of oral contraceptives, so those points are not awarded.""}",17.0
"History of Present Illness
A 62-year-old woman visits the emergency department with acute onset of chest pain and shortness of breath that started 2 hours ago after a heated argument with her son. She describes the pain as crushing and radiating to her left arm. She has had intermittent episodes of chest tightness in the past year, typically during stressful situations, but never as severe as this. She denies nausea, vomiting, or syncope.

  Past Medical History
She has a 10-year history of hypertension and osteoarthritis but has no known history of coronary artery disease. She is on lisinopril and acetaminophen. She has no family history of cardiac conditions or sudden death. She denies smoking or alcohol use.

  Physical Examination
VITALS: BP 145/90 mmHg, pulse 100/min, temperature 98.4°F. 
GEN: Mildly anxious, diaphoretic. 
CARDIAC: Tachycardic, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, no hepatosplenomegaly. 
EXT: No cyanosis or edema. 
SKIN: Warm and dry.

  Laboratory Results
Troponin I is elevated at 3.5 ng/mL. Serum brain natriuretic peptide (BNP) is 280 pg/mL. Electrocardiogram (ECG) shows ST-segment elevation in leads V2-V4. ",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Acute Myocardial Infarction (MI)**: The patient's symptoms of crushing chest pain radiating to the left arm, shortness of breath, and elevated troponin I level are consistent with an acute MI. The ST-segment elevation in leads V2-V4 on the ECG also supports this diagnosis.
2. **Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**: The patient's symptoms started after a heated argument, which could be a stress trigger. The presence of chest pain, shortness of breath, and elevated troponin I level, along with the absence of a clear history of coronary artery disease, could suggest stress-induced cardiomyopathy.
3. **Acute Coronary Syndrome (ACS) with possible Unstable Angina**: The patient's history of intermittent chest tightness during stressful situations, along with the current episode of severe chest pain and shortness of breath, could indicate ACS with possible unstable angina. The elevated troponin I level and ST-segment elevation on the ECG also support this diagnosis.","Here are the findings/risk factors supporting each possible diagnosis:

**1. Acute Myocardial Infarction (MI)**

* Supporting findings:
	+ Elevated troponin I level (3.5 ng/mL), which is a specific marker for cardiac damage
	+ ST-segment elevation in leads V2-V4 on the ECG, which is a classic sign of an acute MI
	+ Crushing chest pain radiating to the left arm, which is a typical symptom of an MI
	+ Shortness of breath, which can occur due to decreased cardiac output and pulmonary congestion
* Risk factors:
	+ Hypertension (10-year history), which is a major risk factor for coronary artery disease and MI
	+ Age (62 years), which increases the risk of MI
	+ Stressful situation (heated argument), which can trigger an MI in susceptible individuals

**2. Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**

* Supporting findings:
	+ Stressful trigger (heated argument), which is a common precipitant of stress-induced cardiomyopathy
	+ Absence of a clear history of coronary artery disease, which makes an acute MI less likely
	+ Elevated troponin I level, which can occur in stress-induced cardiomyopathy due to cardiac stunning
	+ Shortness of breath and chest pain, which can occur due to left ventricular dysfunction
* Risk factors:
	+ Female sex, which is more commonly affected by stress-induced cardiomyopathy
	+ Age (62 years), which is within the typical age range for stress-induced cardiomyopathy
	+ Stressful situation (heated argument), which can trigger stress-induced cardiomyopathy in susceptible individuals

**3. Acute Coronary Syndrome (ACS) with possible Unstable Angina**

* Supporting findings:
	+ Intermittent chest tightness during stressful situations, which suggests a possible chronic coronary artery disease process
	+ Elevated troponin I level, which can occur in ACS due to cardiac damage
	+ ST-segment elevation in leads V2-V4 on the ECG, which can occur in ACS due to coronary artery occlusion
	+ Shortness of breath and chest pain, which can occur due to decreased cardiac output and pulmonary congestion
* Risk factors:
	+ Hypertension (10-year history), which is a major risk factor for coronary artery disease and ACS
	+ Age (62 years), which increases the risk of ACS
	+ Stressful situation (heated argument), which can trigger ACS in susceptible individuals
	+ Intermittent chest tightness during stressful situations, which suggests a possible chronic coronary artery disease process","Here are the findings opposing each possible diagnosis, or findings that were expected but not present:

**1. Acute Myocardial Infarction (MI)**

* Opposing findings:
	+ Absence of nausea, vomiting, or syncope, which are common symptoms of an MI
	+ No family history of cardiac conditions or sudden death, which could suggest a lower risk of MI
	+ No history of smoking or alcohol use, which are major risk factors for coronary artery disease and MI
	+ The patient's symptoms started after a stressful situation, which could suggest a non-cardiac cause
* Expected findings that are not present:
	+ Q-waves on the ECG, which are often seen in MI
	+ Segmental wall motion abnormalities on echocardiography, which are often seen in MI
	+ Elevated creatine kinase (CK) or CK-MB levels, which are often seen in MI
	+ Leukocytosis or elevated inflammatory markers, which are often seen in MI

**2. Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**

* Opposing findings:
	+ The patient's symptoms are more typical of an acute coronary syndrome, with crushing chest pain radiating to the left arm
	+ The presence of ST-segment elevation in leads V2-V4 on the ECG, which is more typical of an acute MI
	+ The elevated troponin I level, which is higher than what is typically seen in stress-induced cardiomyopathy
	+ The patient's age (62 years) is slightly older than the typical age range for stress-induced cardiomyopathy
* Expected findings that are not present:
	+ A more dramatic response to stress, such as a severe emotional or physical event
	+ A more typical ""apical ballooning"" pattern on echocardiography, which is often seen in stress-induced cardiomyopathy
	+ A more significant elevation in BNP levels, which is often seen in stress-induced cardiomyopathy
	+ A more rapid resolution of symptoms and ECG changes, which is often seen in stress-induced cardiomyopathy

**3. Acute Coronary Syndrome (ACS) with possible Unstable Angina**

* Opposing findings:
	+ The presence of ST-segment elevation in leads V2-V4 on the ECG, which is more typical of an acute MI
	+ The elevated troponin I level, which is higher than what is typically seen in unstable angina
	+ The patient's symptoms are more severe than what is typically seen in unstable angina
	+ The absence of a clear history of coronary artery disease, which makes ACS less likely
* Expected findings that are not present:
	+ A history of increasing frequency or severity of angina symptoms, which is often seen in ACS
	+ A history of recent physical exertion or activity, which can trigger ACS
	+ ECG changes such as T-wave inversion or ST-segment depression, which are often seen in ACS
	+ Elevated CK or CK-MB levels, which are often seen in ACS","Based on the patient's presentation, history, physical examination, and laboratory results, the final diagnosis is:

**Acute Myocardial Infarction (MI)**

The diagnosis of acute MI is supported by the following findings:

* Crushing chest pain radiating to the left arm, which is a typical symptom of an MI
* Shortness of breath, which can occur due to decreased cardiac output and pulmonary congestion
* Elevated troponin I level (3.5 ng/mL), which is a specific marker for cardiac damage
* ST-segment elevation in leads V2-V4 on the ECG, which is a classic sign of an acute MI
* Hypertension (10-year history), which is a major risk factor for coronary artery disease and MI

While the patient's symptoms started after a stressful situation, which could suggest stress-induced cardiomyopathy, the presence of ST-segment elevation and elevated troponin I level are more consistent with an acute MI. Additionally, the patient's age, hypertension, and lack of other symptoms such as nausea or vomiting, make acute MI a more likely diagnosis.

The patient should be managed according to the standard protocol for acute MI, including:

* Immediate administration of aspirin, beta blockers, and nitrates
* Activation of the cardiac catheterization laboratory for potential percutaneous coronary intervention (PCI)
* Monitoring of cardiac rhythm and hemodynamics
* Administration of anticoagulant therapy, such as heparin or low-molecular-weight heparin
* Consideration of thrombolytic therapy if PCI is not available

It is essential to note that the patient's diagnosis and management should be individualized, and the treatment plan may vary depending on the patient's specific needs and circumstances.","Based on the final diagnosis of Acute Myocardial Infarction (MI), the following additional steps should be taken:

1. **Cardiac Catheterization Laboratory Activation**: Activate the cardiac catheterization laboratory to prepare for potential percutaneous coronary intervention (PCI) to restore blood flow to the affected coronary artery.
2. **Echocardiogram**: Perform an echocardiogram to assess left ventricular function, wall motion, and potential complications such as mitral regurgitation or ventricular septal defect.
3. **Serial Troponin Levels**: Obtain serial troponin levels to monitor the extent of cardiac damage and assess the effectiveness of treatment.
4. **Electrocardiogram (ECG) Monitoring**: Continuously monitor the patient's ECG to detect any potential arrhythmias or changes in the ST-segment elevation.
5. **Cardiac Enzyme Monitoring**: Monitor cardiac enzyme levels, such as CK-MB and lactate dehydrogenase (LDH), to assess the extent of cardiac damage.
6. **Anticoagulation Therapy**: Administer anticoagulant therapy, such as heparin or low-molecular-weight heparin, to prevent further thrombus formation and reduce the risk of complications.
7. **Beta Blocker Therapy**: Continue beta blocker therapy to reduce myocardial oxygen demand and prevent further cardiac damage.
8. **Nitrates and Morphine**: Administer nitrates and morphine as needed to manage chest pain and reduce myocardial oxygen demand.
9. **Fluid Management**: Monitor the patient's fluid status and manage fluid administration to maintain optimal cardiac output and prevent complications such as pulmonary edema.
10. **Consultation with Cardiology**: Consult with a cardiologist to discuss the patient's management plan, including potential interventions such as PCI or coronary artery bypass grafting (CABG).

Additionally, the following tests may be ordered to further evaluate the patient's condition:

* **Coronary Angiography**: To visualize the coronary arteries and identify any blockages or stenosis.
* **Cardiac Magnetic Resonance Imaging (MRI)**: To assess left ventricular function, wall motion, and potential complications such as myocardial rupture.
* **Stress Test**: To assess the patient's functional capacity and detect any potential ischemia or arrhythmias.

The patient should be closely monitored in the intensive care unit (ICU) or a step-down unit, with frequent assessments of their cardiac rhythm, hemodynamics, and overall clinical status.","{""Score"":3,""Rationale"":""The answer includes Acute Myocardial Infarction (MI), Takotsubo Cardiomyopathy (stress‑induced cardiomyopathy), and Unstable Angina, matching all three items in the rubric.""}","{""Score"":6,""Rationale"":""The answer includes all three diagnoses from the rubric—Acute Myocardial Infarction, Takotsubo (Stress‑Induced) Cardiomyopathy, and Unstable Angina (as part of ACS with possible Unstable Angina)—matching the concepts required for full credit.""}","{""Score"":0,""Rationale"":""Student answer does not match any of the specific concepts listed in the rubric for Takotsubo cardiomyopathy, acute MI, or unstable angina; therefore no points are awarded.""}","{""Score"":0,""Rationale"":""The response identifies the condition as Acute Myocardial Infarction (MI) rather than the specific diagnosis required by the rubric, Acute Coronary Syndrome (Anterior STEMI). The rubric only awards points for the exact concept (or exact synonym) of Anterior STEMI, which the answer does not provide.""}","{""Score"":4,""Rationale"":""The answer includes a follow‑up echocardiogram and a cardiology consultation, matching items 2 and 4 of the rubric (2 points each). It mentions beta‑blocker therapy but omits ACE‑inhibitors, so the supportive‑care item is incomplete and receives no points. Psychological support is not addressed. Total points = 4.""}",13.0
"History of Present Illness
A 65-year-old male with a history of type 2 diabetes and hypertension presents with a 2-hour history of crushing chest pain radiating to his left arm. He describes the pain as severe and constant, beginning after he climbed a flight of stairs. He is also feeling nauseated and sweaty. He is unable to recall a prior history of similar symptoms. He denies shortness of breath or palpitations but admits to feeling unusually fatigued for the last week.

  Past Medical History
Type 2 diabetes mellitus for 15 years, hypertension for 12 years, and hyperlipidemia. He is on metformin and a statin. He has no history of coronary artery disease or previous myocardial infarctions. He is a smoker (30 pack-years) and drinks alcohol occasionally. Family history is significant for cardiovascular disease, with both parents having had myocardial infarctions in their 50s

  Physical Examination
VITALS: BP 160/90 mmHg, pulse 110 bpm, temperature 98.5°F. 
GEN: Anxious and diaphoretic, in moderate distress due to chest pain. 
CARDIAC: Tachycardic, regular rhythm
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: No tenderness or joint swelling. 
EXT: No edema. 
SKIN: Diaphoretic, cool extremities.

  Laboratory Results
Troponin I: 3.2 ng/mL (elevated). CBC: Normal. Serum glucose: 180 mg/dL (elevated).",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Acute Myocardial Infarction (MI)**: The patient's symptoms of crushing chest pain radiating to the left arm, nausea, sweating, and elevated troponin I level are consistent with an acute MI.
2. **Unstable Angina**: The patient's chest pain and electrocardiogram (ECG) findings (although not provided) may suggest unstable angina, which is a precursor to an MI.
3. **Acute Coronary Syndrome (ACS)**: This is a broader diagnosis that encompasses both MI and unstable angina, and is characterized by a sudden reduction in blood flow to the heart, which can cause chest pain and other symptoms.

Note: Other possible diagnoses, such as pulmonary embolism or aortic dissection, are less likely given the patient's presentation and laboratory results.","Here are the findings and risk factors that support each of the 3 possible diagnoses:

**1. Acute Myocardial Infarction (MI)**

* Supporting findings:
	+ Elevated troponin I level (3.2 ng/mL), which is a specific marker for cardiac damage
	+ Crushing chest pain radiating to the left arm, which is a classic symptom of MI
	+ Nausea and sweating, which are common accompanying symptoms of MI
	+ Tachycardia (pulse 110 bpm) and hypertension (BP 160/90 mmHg), which can be seen in MI due to pain and stress
* Risk factors:
	+ 30 pack-year smoking history, which increases the risk of coronary artery disease and MI
	+ Family history of cardiovascular disease, with both parents having had MIs in their 50s
	+ History of hypertension, hyperlipidemia, and type 2 diabetes mellitus, which are all risk factors for coronary artery disease and MI

**2. Unstable Angina**

* Supporting findings:
	+ Chest pain at rest, which is a characteristic feature of unstable angina
	+ Recent onset of fatigue, which may be a symptom of reduced cardiac output
	+ Tachycardia (pulse 110 bpm) and hypertension (BP 160/90 mmHg), which can be seen in unstable angina due to pain and stress
* Risk factors:
	+ Same risk factors as for MI, including smoking history, family history of cardiovascular disease, and history of hypertension, hyperlipidemia, and type 2 diabetes mellitus
	+ Note that unstable angina is often a precursor to MI, and the patient's symptoms and risk factors suggest that he may be at high risk for an MI

**3. Acute Coronary Syndrome (ACS)**

* Supporting findings:
	+ Combination of chest pain, nausea, sweating, and tachycardia, which are all symptoms of ACS
	+ Elevated troponin I level (3.2 ng/mL), which suggests cardiac damage and is consistent with ACS
	+ Recent onset of fatigue, which may be a symptom of reduced cardiac output
* Risk factors:
	+ Same risk factors as for MI and unstable angina, including smoking history, family history of cardiovascular disease, and history of hypertension, hyperlipidemia, and type 2 diabetes mellitus
	+ Note that ACS is a broad term that encompasses both MI and unstable angina, and the patient's symptoms and risk factors suggest that he may be at high risk for an ACS event.","Here are the findings that oppose each of the 3 possible diagnoses, or findings that were expected but not present:

**1. Acute Myocardial Infarction (MI)**

* Opposing findings:
	+ The patient's chest pain is relatively short-lived (2 hours), whereas MI often presents with prolonged chest pain
	+ The patient does not report any shortness of breath, which is a common symptom of MI, especially in patients with pre-existing cardiovascular disease
	+ The patient's physical examination does not reveal any signs of heart failure, such as jugular venous distension or pedal edema
* Expected but not present findings:
	+ Electrocardiogram (ECG) changes, such as ST-segment elevation or Q-waves, which are often seen in MI
	+ Elevated creatine kinase (CK) or CK-MB levels, which can also indicate cardiac damage
	+ A more significant elevation in troponin I level, as the current level of 3.2 ng/mL is relatively mild

**2. Unstable Angina**

* Opposing findings:
	+ The patient's troponin I level is elevated (3.2 ng/mL), which suggests cardiac damage and is more consistent with MI than unstable angina
	+ The patient's chest pain is described as severe and constant, whereas unstable angina often presents with more variable or intermittent pain
	+ The patient's physical examination does not reveal any signs of cardiac ischemia, such as a new murmur or a pericardial friction rub
* Expected but not present findings:
	+ ECG changes, such as ST-segment depression or T-wave inversion, which can indicate cardiac ischemia
	+ A history of recent exertion or stress that triggered the chest pain, as unstable angina often occurs in response to increased cardiac demand
	+ A more gradual onset of symptoms, as unstable angina often develops over hours or days rather than suddenly

**3. Acute Coronary Syndrome (ACS)**

* Opposing findings:
	+ The patient's physical examination does not reveal any signs of cardiac dysfunction, such as a new murmur or a pericardial friction rub
	+ The patient's laboratory results do not show any significant elevation in inflammatory markers, such as C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR), which can be seen in ACS
	+ The patient's symptoms are relatively short-lived (2 hours), whereas ACS often presents with more prolonged or recurrent symptoms
* Expected but not present findings:
	+ ECG changes, such as ST-segment elevation or depression, which can indicate cardiac ischemia or infarction
	+ A more significant elevation in troponin I level, as the current level of 3.2 ng/mL is relatively mild
	+ A history of recent exertion or stress that triggered the symptoms, as ACS often occurs in response to increased cardiac demand","Based on the patient's presentation, laboratory results, and risk factors, the final diagnosis is:

**Acute Myocardial Infarction (MI)**

The patient's symptoms of crushing chest pain radiating to the left arm, nausea, sweating, and shortness of breath (although not explicitly reported, the patient is feeling unusually fatigued and anxious) are consistent with an acute MI. The elevated troponin I level (3.2 ng/mL) is a specific marker for cardiac damage and supports the diagnosis of MI.

The patient's risk factors, including a 30 pack-year smoking history, family history of cardiovascular disease, and history of hypertension, hyperlipidemia, and type 2 diabetes mellitus, also increase the likelihood of an MI.

While the patient's symptoms and laboratory results could also be consistent with unstable angina or acute coronary syndrome (ACS), the elevated troponin I level and the patient's symptoms suggest that cardiac damage has occurred, making MI the most likely diagnosis.

**Type of MI:** Based on the patient's symptoms and laboratory results, this is likely a **Non-ST-Elevation Myocardial Infarction (NSTEMI)**, as the patient's ECG results are not provided, but the elevated troponin I level and the patient's symptoms are consistent with an NSTEMI.

**Next steps:**

* The patient should be immediately referred to a cardiac catheterization laboratory for coronary angiography and possible percutaneous coronary intervention (PCI) or thrombolysis.
* The patient should be started on aspirin, beta-blockers, and nitrates, as well as other medications as indicated, such as anticoagulants and statins.
* The patient's vital signs and cardiac rhythm should be closely monitored, and the patient should be prepared for possible complications, such as heart failure or arrhythmias.","Based on the patient's diagnosis of Acute Myocardial Infarction (MI), the following additional steps should be taken:

**Immediate Steps:**

1. **Administer oxygen**: Provide oxygen therapy to help increase oxygen delivery to the heart and other tissues.
2. **Initiate cardiac monitoring**: Continuously monitor the patient's cardiac rhythm, blood pressure, and oxygen saturation.
3. **Establish intravenous access**: Insert an intravenous line to administer medications and fluids as needed.
4. **Administer aspirin**: Give the patient a dose of aspirin (162-325 mg) to help reduce platelet aggregation and prevent further clotting.
5. **Administer nitrates**: Give the patient a dose of nitrates (e.g., nitroglycerin) to help dilate blood vessels and reduce cardiac workload.
6. **Administer beta-blockers**: Give the patient a dose of beta-blockers (e.g., metoprolol) to help reduce cardiac workload and prevent arrhythmias.
7. **Administer anticoagulants**: Give the patient a dose of anticoagulants (e.g., heparin) to help prevent further clotting.

**Diagnostic Steps:**

1. **Electrocardiogram (ECG)**: Perform a 12-lead ECG to assess for signs of ischemia or infarction.
2. **Echocardiogram**: Perform an echocardiogram to assess left ventricular function and detect any wall motion abnormalities.
3. **Cardiac biomarkers**: Measure cardiac biomarkers (e.g., troponin I, CK-MB) to assess the extent of cardiac damage.
4. **Complete blood count (CBC)**: Perform a CBC to assess for any signs of infection or inflammation.
5. **Basic metabolic panel (BMP)**: Perform a BMP to assess electrolyte levels and renal function.

**Therapeutic Steps:**

1. **Percutaneous coronary intervention (PCI)**: Consider PCI (e.g., angioplasty, stenting) to restore blood flow to the affected coronary artery.
2. **Thrombolysis**: Consider thrombolysis (e.g., tPA) to dissolve the clot and restore blood flow to the affected coronary artery.
3. **Antiplatelet therapy**: Continue antiplatelet therapy (e.g., aspirin, P2Y12 inhibitors) to prevent further clotting.
4. **Anticoagulant therapy**: Continue anticoagulant therapy (e.g., heparin, warfarin) to prevent further clotting.
5. **Beta-blocker therapy**: Continue beta-blocker therapy to reduce cardiac workload and prevent arrhythmias.

**Consultations:**

1. **Cardiology consultation**: Consult with a cardiologist to discuss the patient's diagnosis and treatment plan.
2. **Interventional cardiology consultation**: Consult with an interventional cardiologist to discuss the possibility of PCI or thrombolysis.
3. **Cardiothoracic surgery consultation**: Consult with a cardiothoracic surgeon to discuss the possibility of coronary artery bypass grafting (CABG) if PCI or thrombolysis is not feasible.

**Discharge Planning:**

1. **Medication management**: Ensure the patient is taking all prescribed medications as directed.
2. **Lifestyle modifications**: Counsel the patient on lifestyle modifications (e.g., diet, exercise, smoking cessation) to reduce the risk of future cardiovascular events.
3. **Follow-up appointments**: Schedule follow-up appointments with the patient's primary care physician and cardiologist to monitor the patient's progress and adjust the treatment plan as needed.","{""Score"":2,""Rationale"":""The answer includes Acute Myocardial Infarction and Unstable Angina, which match two items in the rubric. The third listed diagnosis (Acute Coronary Syndrome) does not match Gastroesophageal Reflux Disease, so only 2 of 3 points are awarded.""}","{""Score"":4,""Rationale"":""The answer correctly identified and described Acute Myocardial Infarction and Unstable Angina with appropriate findings and risk factors, matching the rubric (2 points each). However, the third diagnosis provided was Acute Coronary Syndrome instead of Gastroesophageal Reflux Disease, which does not match the rubric, so no points were awarded for that part.""}","{""Score"":2,""Rationale"":""Student correctly noted troponin elevation as opposing Unstable Angina, matching the rubric; however, they provided opposing findings for MI (rubric expects none) and omitted GERD entirely, so only 2 of the possible 6 points are earned.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Acute Myocardial Infarction (MI) and includes the key features from the rubric (crushing chest pain, elevated troponin, and significant cardiac risk factors), matching the high‑scoring example.""}","{""Score"":4,""Rationale"":""Student correctly includes aspirin and heparin (matches rubric point 1) and nitroglycerin (matches rubric point 2). However, they do not mention cardiac catheterization or coronary angiography as a diagnostic step (rubric point 3), so no points for that item.""}",14.0
"History of Present Illness
A 60-year-old male with a recent history of hip replacement surgery 2 weeks ago presents with sudden onset of shortness of breath and pleuritic chest pain. The pain is sharp and worsens with deep breathing or coughing. He has been feeling progressively more breathless, even while at rest, and also reports a mild cough. He denies fever or hemoptysis but admits to feeling fatigued and dizzy on exertion. He has not been able to move around much post-surgery, and has been primarily confined to bed. He has no known history of deep vein thrombosis (DVT).

  Past Medical History
He has a history of osteoarthritis, for which he underwent the recent hip replacement. He has no known history of cardiovascular or respiratory disease. No significant family history of pulmonary embolism or clotting disorders. He is a non-smoker and does not drink alcohol.

  Physical Examination
VITALS: BP 130/85 mmHg, pulse 110 bpm, temperature 98.7°F, respiratory rate 22/min. GEN: Mildly anxious, appears in moderate distress due to breathing difficulties. CARDIAC: Tachycardic, regular rhythm, no murmurs. 
PULM: Tachypneic, decreased breath sounds at the right base, no wheezing. 
ABD: Soft, non-tender. 
MSK: Limited movement of the right hip due to recent surgery. 
EXT: Mild swelling in the right lower leg, no redness or warmth. 
SKIN: No rashes, warm extremities.

  Laboratory Results
D-dimer: 8.5 µg/mL (elevated). Chest CT angiogram: Acute pulmonary embolism in the right lower lobe pulmonary artery. ABG: pO2 70 mmHg, pCO2 35 mmHg.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Pulmonary Embolism (PE)**: The patient's symptoms of sudden onset shortness of breath, pleuritic chest pain, and elevated D-dimer, along with the chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery, strongly support this diagnosis.
2. **Deep Vein Thrombosis (DVT)**: The patient's recent history of hip replacement surgery, immobility, and mild swelling in the right lower leg suggest a possible DVT, which could be a source of the pulmonary embolism.
3. **Pneumonia**: Although the patient denies fever and hemoptysis, the symptoms of shortness of breath, pleuritic chest pain, and decreased breath sounds at the right base could also be consistent with pneumonia, particularly if the pulmonary embolism has caused infarction of the lung tissue. However, the chest CT angiogram and laboratory results make PE a more likely diagnosis.","Here are the findings and risk factors supporting each possible diagnosis:

**1. Pulmonary Embolism (PE)**

* Supporting findings:
	+ Sudden onset of shortness of breath and pleuritic chest pain
	+ Elevated D-dimer (8.5 µg/mL)
	+ Chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery
	+ Decreased breath sounds at the right base on physical examination
	+ Tachypnea (respiratory rate 22/min) and tachycardia (pulse 110 bpm)
* Risk factors:
	+ Recent hip replacement surgery, which increases the risk of venous thromboembolism (VTE)
	+ Immobility due to recent surgery, which increases the risk of VTE
	+ Age (60 years), which is a risk factor for VTE

**2. Deep Vein Thrombosis (DVT)**

* Supporting findings:
	+ Mild swelling in the right lower leg
	+ Recent hip replacement surgery, which increases the risk of VTE
	+ Immobility due to recent surgery, which increases the risk of VTE
* Risk factors:
	+ Recent hip replacement surgery, which increases the risk of VTE
	+ Immobility due to recent surgery, which increases the risk of VTE
	+ Age (60 years), which is a risk factor for VTE
	+ Limited movement of the right hip due to recent surgery, which may increase the risk of DVT

**3. Pneumonia**

* Supporting findings:
	+ Shortness of breath and pleuritic chest pain
	+ Decreased breath sounds at the right base on physical examination
	+ Tachypnea (respiratory rate 22/min)
* Risk factors:
	+ Recent surgery, which may increase the risk of aspiration pneumonia
	+ Age (60 years), which is a risk factor for pneumonia
	+ Immobility due to recent surgery, which may increase the risk of pneumonia
	+ However, the lack of fever, hemoptysis, and other typical symptoms of pneumonia, as well as the presence of a clear alternative diagnosis (PE), make this diagnosis less likely.","Here are the findings opposing each possible diagnosis, or findings that were expected but not present:

**1. Pulmonary Embolism (PE)**

* Opposing findings:
	+ The patient's oxygen saturation is not severely impaired (pO2 70 mmHg), which might be expected in a larger or more central PE.
	+ The patient does not have a history of DVT or previous VTE, which is a common risk factor for PE.
	+ The patient does not have a family history of clotting disorders or thrombophilia, which could increase the risk of PE.
* Expected findings that are not present:
	+ Hemoptysis, which can occur in up to 20% of patients with PE, is not present in this patient.
	+ Syncope, which can occur in patients with large or saddle-shaped PEs, is not reported in this patient.
	+ A more significant drop in blood pressure, which can occur in patients with large PEs, is not seen in this patient (BP 130/85 mmHg).

**2. Deep Vein Thrombosis (DVT)**

* Opposing findings:
	+ The patient does not have significant redness, warmth, or tenderness in the affected leg, which are common symptoms of DVT.
	+ The patient does not have a history of previous DVT or VTE, which is a common risk factor for recurrent DVT.
	+ The swelling in the right lower leg is mild, which might not be consistent with a significant DVT.
* Expected findings that are not present:
	+ Significant leg pain or tenderness, which is a common symptom of DVT, is not reported in this patient.
	+ A positive Homan's sign (pain in the calf when the foot is dorsiflexed), which can be seen in patients with DVT, is not mentioned in this patient.
	+ A more significant difference in leg circumference between the affected and unaffected legs, which can be seen in patients with DVT, is not reported in this patient.

**3. Pneumonia**

* Opposing findings:
	+ The patient does not have a fever (temperature 98.7°F), which is a common symptom of pneumonia.
	+ The patient does not have a productive cough or hemoptysis, which can be seen in patients with pneumonia.
	+ The chest CT angiogram shows a pulmonary embolism, which is not consistent with pneumonia.
* Expected findings that are not present:
	+ Crackles or wheezing on lung exam, which can be seen in patients with pneumonia, are not reported in this patient.
	+ A higher white blood cell count, which can be seen in patients with pneumonia, is not mentioned in this patient.
	+ A more significant impairment in oxygen saturation, which can be seen in patients with pneumonia, is not present in this patient (pO2 70 mmHg).","Based on the patient's presentation, physical examination, laboratory results, and imaging studies, the final diagnosis is:

**Acute Pulmonary Embolism (PE)**

The diagnosis is supported by the following key findings:

* Sudden onset of shortness of breath and pleuritic chest pain
* Elevated D-dimer (8.5 µg/mL)
* Chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery
* Decreased breath sounds at the right base on physical examination
* Tachypnea (respiratory rate 22/min) and tachycardia (pulse 110 bpm)
* Recent hip replacement surgery, which increases the risk of venous thromboembolism (VTE)

The patient's symptoms, laboratory results, and imaging studies are all consistent with an acute pulmonary embolism. The presence of a pulmonary embolism on the chest CT angiogram is diagnostic, and the patient's clinical presentation is consistent with this diagnosis.

The patient's recent hip replacement surgery and immobility are likely contributing factors to the development of the pulmonary embolism. The patient's age (60 years) and lack of previous history of DVT or VTE are also relevant factors in this diagnosis.

Treatment for the patient should include anticoagulation therapy, such as heparin or low-molecular-weight heparin, and possibly thrombolytic therapy if the patient is hemodynamically unstable. The patient should also be closely monitored for signs of clinical deterioration and for the development of any complications.","Based on the final diagnosis of acute pulmonary embolism (PE), the following additional steps should be taken:

1. **Initiate anticoagulation therapy**: The patient should be started on anticoagulation therapy, such as heparin or low-molecular-weight heparin, to prevent further clot formation and to reduce the risk of recurrent PE.
2. **Monitor vital signs and oxygen saturation**: The patient's vital signs, including oxygen saturation, should be closely monitored to ensure that they are stable and not deteriorating.
3. **Order a lower extremity Doppler ultrasound**: To evaluate for the presence of a deep vein thrombosis (DVT) in the legs, which could be the source of the pulmonary embolism.
4. **Consider thrombolytic therapy**: If the patient is hemodynamically unstable or has a large PE, thrombolytic therapy may be considered to dissolve the clot and improve cardiac output.
5. **Consult with a cardiologist or pulmonologist**: To discuss the patient's management and to determine the best course of treatment.
6. **Order an ECG and troponin level**: To evaluate for any signs of cardiac strain or injury.
7. **Consider placement of an inferior vena cava (IVC) filter**: If the patient has a contraindication to anticoagulation or has a high risk of recurrent PE.
8. **Optimize the patient's oxygenation and ventilation**: To ensure that the patient is receiving adequate oxygen and to prevent further respiratory compromise.
9. **Monitor for signs of complications**: Such as hypotension, cardiac arrest, or respiratory failure, and to be prepared to intervene if necessary.
10. **Develop a plan for long-term anticoagulation**: To prevent recurrent PE and to determine the best anticoagulant regimen for the patient.

Additionally, the following tests may be ordered to evaluate the patient's underlying risk factors for PE and to guide management:

* **Coagulation studies**: To evaluate for any underlying coagulopathy or thrombophilia.
* **Factor V Leiden mutation testing**: To evaluate for the presence of a genetic mutation that increases the risk of thrombosis.
* **Antithrombin III level**: To evaluate for any deficiency in antithrombin III, which can increase the risk of thrombosis.
* **Protein C and protein S levels**: To evaluate for any deficiency in these proteins, which can increase the risk of thrombosis.

These tests can help to identify any underlying risk factors for PE and to guide management to prevent recurrent events.","{""Score"":3,""Rationale"":""Student listed Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), and Pneumonia, matching all three concepts in the rubric.""}","{""Score"":6,""Rationale"":""Student's answer includes all key concepts for Pulmonary Embolism, Pneumonia, and Deep Vein Thrombosis as outlined in the rubric, matching the high‑scoring example for each diagnosis.""}","{""Score"":4,""Rationale"":""The answer correctly identifies opposing findings for Pneumonia (absence of fever and crackles) and DVT (no redness, warmth, or prior DVT), matching concepts in the high‑scoring example, earning 2 points each. For PE, the rubric’s high‑scoring example notes no opposing findings, whereas the student listed several opposing findings, so no points are awarded for PE. Total score is 4 out of 6.""}","{""Score"":2,""Rationale"":""Student answer matches all key concepts from the high scoring example, including diagnosis of pulmonary embolism, sudden shortness of breath, pleuritic chest pain, elevated D-dimer, and CT angiogram confirmation.""}","{""Score"":4,""Rationale"":""The answer includes anticoagulation initiation and ordering a lower extremity ultrasound, matching two rubric items (2 points each). It mentions monitoring and optimizing oxygenation but does not explicitly state oxygen therapy to improve saturation, so no points for that item.""}",19.0
"History of Present Illness
A 74-year-old female presents with a 1-month history of progressive fatigue, dizziness, and pale appearance. Over the last two weeks, she has noticed intermittent black, tarry stools and occasional bright red blood after bowel movements. She denies significant abdominal pain, nausea, or vomiting but mentions a history of occasional heartburn, which she manages with over-the-counter antacids. She has no history of hemorrhoids or significant gastrointestinal issues. She does not recall recent weight loss, but reports feeling more fatigued than usual.

  Past Medical History
She has a history of hypertension, controlled with an angiotensin II receptor blocker, and osteoarthritis. She is a former smoker (quit 10 years ago) and consumes alcohol occasionally. No family history of gastrointestinal cancers or bleeding disorders.

  Physical Examination
VITALS: BP 110/70 mmHg, pulse 88 bpm, temperature 98.2°F. 
GEN: Pale and fatigued-appearing. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild epigastric tenderness, no hepatosplenomegaly. No rebound tenderness or guarding. 
EXT: No edema, peripheral pulses intact. 
SKIN: Pale conjunctiva, no jaundice.

  Laboratory Results
Hemoglobin: 8.9 g/dL (low). Hematocrit: 27% (low). Platelets: 150 x 10^3/μL. Fecal occult blood test: Positive. Colonoscopy: Findings of multiple diverticula with no active bleeding. No masses or polyps observed.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Diverticular Disease with Bleeding**: The patient's colonoscopy showed multiple diverticula, and her symptoms of black, tarry stools and occasional bright red blood are consistent with diverticular bleeding.
2. **Gastrointestinal Ulcer**: The patient's history of occasional heartburn and use of over-the-counter antacids, combined with her symptoms of black, tarry stools, suggest the possibility of a gastrointestinal ulcer, such as a gastric or duodenal ulcer.
3. **Angiodysplasia**: The patient's age and symptoms of intermittent gastrointestinal bleeding, along with the absence of other obvious sources of bleeding on colonoscopy, raise the possibility of angiodysplasia, a condition characterized by abnormal blood vessels in the gastrointestinal tract that can cause bleeding.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Diverticular Disease with Bleeding**

* Supportive findings:
	+ Colonoscopy showing multiple diverticula
	+ Positive fecal occult blood test
	+ Symptoms of black, tarry stools and occasional bright red blood, which are consistent with lower gastrointestinal bleeding
* Risk factors:
	+ Age (74 years old, diverticular disease is more common in older adults)
	+ Lack of significant abdominal pain, which is consistent with diverticular bleeding (diverticulitis typically presents with more significant pain)

**2. Gastrointestinal Ulcer**

* Supportive findings:
	+ History of occasional heartburn, which may indicate gastroesophageal reflux disease (GERD) or peptic ulcer disease
	+ Use of over-the-counter antacids, which may suggest a history of gastrointestinal symptoms
	+ Symptoms of black, tarry stools, which could indicate upper gastrointestinal bleeding
* Risk factors:
	+ Age (74 years old, peptic ulcer disease is more common in older adults)
	+ History of hypertension, which may be associated with non-steroidal anti-inflammatory drug (NSAID) use, a risk factor for gastrointestinal ulcers
	+ Former smoker, which may increase the risk of peptic ulcer disease

**3. Angiodysplasia**

* Supportive findings:
	+ Age (74 years old, angiodysplasia is more common in older adults)
	+ Symptoms of intermittent gastrointestinal bleeding, which is consistent with angiodysplasia
	+ Lack of other obvious sources of bleeding on colonoscopy, which may suggest a vascular cause of bleeding
* Risk factors:
	+ Age (74 years old, as mentioned earlier)
	+ History of hypertension, which may be associated with vascular disease and angiodysplasia
	+ Former smoker, which may increase the risk of vascular disease and angiodysplasia","Here are the findings that oppose each of the possible diagnoses, or findings that were expected but not present:

**1. Diverticular Disease with Bleeding**

* Opposing findings:
	+ The patient's colonoscopy did not show active bleeding, which might be expected if diverticular disease was the primary cause of bleeding
	+ The patient's symptoms of bleeding are intermittent, which is less typical of diverticular disease (although it can occur)
* Expected but not present findings:
	+ Significant abdominal pain or tenderness, which is often associated with diverticulitis (although diverticular bleeding can occur without significant pain)
	+ A more significant drop in hemoglobin or hematocrit over a shorter period, which might be expected if the bleeding was more severe

**2. Gastrointestinal Ulcer**

* Opposing findings:
	+ The patient's colonoscopy did not show any evidence of ulcers or erosions in the colon
	+ The patient's symptoms of black, tarry stools and occasional bright red blood are more typical of lower gastrointestinal bleeding, whereas ulcers typically cause upper gastrointestinal bleeding
* Expected but not present findings:
	+ Epigastric pain or tenderness, which is often associated with peptic ulcer disease
	+ A history of NSAID use, which is a common risk factor for gastrointestinal ulcers
	+ Evidence of Helicobacter pylori infection, which is a common cause of peptic ulcers

**3. Angiodysplasia**

* Opposing findings:
	+ The patient's colonoscopy did not show any visible angiodysplastic lesions, although these can be difficult to detect
	+ The patient's symptoms of bleeding are not as frequent or severe as might be expected with angiodysplasia
* Expected but not present findings:
	+ A more prolonged history of gastrointestinal bleeding, as angiodysplasia often causes chronic or recurrent bleeding
	+ Evidence of other vascular diseases, such as atherosclerosis or hypertension, which can be associated with angiodysplasia
	+ A family history of bleeding disorders or vascular diseases, which can be associated with angiodysplasia (although this is not always present)","Based on the patient's presentation, laboratory results, and colonoscopy findings, the final diagnosis is:

**Diverticular Disease with Bleeding**

The patient's symptoms of intermittent black, tarry stools and occasional bright red blood, combined with the colonoscopy findings of multiple diverticula, support this diagnosis. Although the colonoscopy did not show active bleeding, the presence of diverticula and the patient's symptoms are consistent with diverticular bleeding.

The patient's age, lack of significant abdominal pain, and the presence of diverticula on colonoscopy also support this diagnosis. While the patient's history of occasional heartburn and use of over-the-counter antacids could suggest a gastrointestinal ulcer, the colonoscopy findings and the patient's symptoms are more consistent with diverticular disease.

Angiodysplasia is also a possible diagnosis, but the lack of visible angiodysplastic lesions on colonoscopy and the patient's symptoms make it less likely.

**Recommendations:**

* The patient should be monitored for signs of ongoing bleeding and anemia.
* Iron supplements may be prescribed to treat the patient's iron deficiency anemia.
* The patient's hypertension and osteoarthritis should be managed as usual.
* The patient should be advised to follow a high-fiber diet to help manage diverticular disease.
* A follow-up colonoscopy may be recommended in the future to monitor for any changes in the patient's diverticula or to check for any new lesions.

**Management of Bleeding:**

* The patient's bleeding is likely to be managed conservatively with iron supplements and monitoring for signs of ongoing bleeding.
* If the bleeding recurs or worsens, further evaluation and treatment may be necessary, such as endoscopic therapy or surgery.","Based on the final diagnosis of Diverticular Disease with Bleeding, the following additional steps can be taken:

1. **Upper Endoscopy**: To rule out any upper gastrointestinal sources of bleeding, an upper endoscopy can be performed. This can help to identify any ulcers, erosions, or other lesions that may be contributing to the patient's bleeding.
2. **Complete Blood Count (CBC) with Differential**: To monitor the patient's anemia and to check for any signs of ongoing bleeding, a CBC with differential can be ordered.
3. **Electrolyte Panel**: To check for any electrolyte imbalances that may be contributing to the patient's symptoms, an electrolyte panel can be ordered.
4. **Stool Studies**: To check for any infections or inflammation that may be contributing to the patient's symptoms, stool studies such as a stool culture or stool test for Clostridioides difficile (C. diff) can be ordered.
5. **Imaging Studies**: To evaluate the patient's diverticula and to check for any other potential sources of bleeding, imaging studies such as a computed tomography (CT) scan or a barium enema can be ordered.
6. **Consultation with a Gastroenterologist**: To get a specialist's opinion on the patient's case and to discuss any further management or treatment options, a consultation with a gastroenterologist can be arranged.
7. **Discussion of Risks and Benefits of Colon Resection**: If the patient's bleeding is severe or recurrent, a discussion of the risks and benefits of colon resection can be had with the patient and their family.
8. **Monitoring for Signs of Ongoing Bleeding**: The patient should be monitored closely for signs of ongoing bleeding, such as hematemesis, melena, or hematochezia, and any changes in their condition should be reported to their healthcare provider promptly.

**Medications:**

* **Iron Supplements**: To treat the patient's iron deficiency anemia, iron supplements can be prescribed.
* **Proton Pump Inhibitors (PPIs)**: To reduce the risk of further bleeding, PPIs can be prescribed to reduce stomach acid.
* **Anti-diarrheal Medications**: To manage any diarrhea or abdominal cramping, anti-diarrheal medications can be prescribed.

**Lifestyle Modifications:**

* **High-Fiber Diet**: To help manage diverticular disease, a high-fiber diet can be recommended.
* **Adequate Hydration**: To help prevent constipation and promote regular bowel movements, adequate hydration can be recommended.
* **Regular Exercise**: To help promote regular bowel movements and overall health, regular exercise can be recommended.","{""Score"":1,""Rationale"":""The answer includes a gastrointestinal ulcer, which matches the rubric's Peptic Ulcer Disease with Upper GI Bleeding (1 point). Diverticular disease and angiodysplasia are not listed in the rubric, so no points for those.""}","{""Score"":2,""Rationale"":""The answer includes a gastrointestinal ulcer, which matches the rubric's Peptic Ulcer Disease (synonymous concept). The other listed diagnoses (Diverticular Disease with Bleeding and Angiodysplasia) are not mentioned in the rubric, so no points are awarded for them.""}","{""Score"":2,""Rationale"":""The answer only includes the concept related to Peptic Ulcer Disease (noting lack of NSAID use), which matches one of the three rubric items (2 points). It does not address the gastritis with chronic GI bleeding criteria (no endoscopic confirmation) nor the gastrointestinal malignancy criteria (no weight loss, mass, or abnormal colonoscopy), so no points are awarded for those.""}","{""Score"":0,""Rationale"":""The response describes diverticular disease with bleeding, which does not match the high‑scoring answer that cites melena, anemia, positive fecal occult blood, heartburn, and absence of lower GI bleeding to support an upper GI source. The answer provides a different diagnosis, so no points are awarded.""}","{""Score"":6,""Rationale"":""Student listed Upper Endoscopy, PPI therapy, and monitoring of anemia (CBC) which correspond to three rubric items; they did not mention Helicobacter pylori assessment, but the three matched items earn the full 6 points as the rubric caps at 6.""}",11.0
,,,,,,,,,,,,,,,,
